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Overview to Thesis Portfolio 
 
This thesis has been conducted in part fulfilment of the Doctorate in Clinical 
Psychology. It comprises two parts: a systematic review and an empirical research 
study. These are two distinct articles both aiming to provide insight into the 
challenges of late life depression.  
 
Firstly, the ageing population will mean that mental health services are likely to see 
an increase in older people with depression, many of whom will have neurological 
conditions common in late life, including dementia, stroke and Parkinson’s disease. 
These conditions have a high risk of depression associated with them. Addressing 
depression can have a significant effect on quality of life and at present there is 
limited evidence for effective treatments for depression in neurological conditions. 
Researchers and therapists have previously been reluctant to conduct psychological 
therapy with this population, however, there is preliminary evidence that 
psychological therapies can be efficacious for this population. CBT is structured, 
goal focused and orientated in the present therefore may be easily adapted for the 
needs of people with neurological conditions and associated cognitive impairment. 
Chapter one presents systematic review of this literature, titled ‘Cognitive and 
behavioural therapies for the treatment of depression in people with dementia, stroke 
and Parkinson’s disease’. 
 
Secondly, depression in the general older adult population will also present 
challenges for mental health services. Psychological therapies have been shown to be 
equally effective for older people as they are for younger adults. However, there are 
a range of gerontological issues that must be considered when working with older 
people. For example, cohort beliefs, interpersonal role changes and physical health 
changes may all impact on the way an older person conceptualises their difficulties. 
In particular, depression in older people has been associated with negative attitudes 
about ageing. Cognitive theory states that attitudes are mood-state dependent and if 
negative or dysfunctional attitudes are modified, this can result in improvement in 
mood. Exploring the attitudes of older people with depression will aid our 
understanding of late life depression and may provide useful information on whether 
attitudes to ageing should be specifically addressed during therapy for depression. 
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The current research study explores attitudes to ageing with a clinical sample of 
depressed older adults and compares attitudes with non depressed control 
participants. Chapter two outlines the full methodology used in the research study 
and chapter three contains the research study, titled ‘Attitudes to ageing and clinical 







































Thesis Portfolio Abstract 
 
Systematic Review: Neurological conditions common in late life include dementia, 
stoke and Parkinson’s disease (PD). Depression in these conditions is common and 
can have significant adverse effects quality of life. Psychological therapies such as 
CBT are effective for late life depression, however, there is a lack of empirical 
evidence for CBT based therapies in the treatment of depression in neurological 
conditions. The current systematic review was therefore carried out to evaluate the 
evidence for cognitive and behavioural therapies in the treatment of depression in 
dementia, stroke and PD. A total of 19 studies were included in the review. It was 
concluded that there is currently insufficient high quality evidence examining CBT 
based therapies in people with these conditions. There are, however, promising 
preliminary results which need to be examined further using high quality research 
designs including long term follow up data.   
 
Empirical Research Study: Depression in older people can have a detrimental 
effect on morbidity and quality of life. Unfortunately it is often unrecognised and 
untreated. Given the challenges associated with ageing, such as losses and physical 
health problems, people may consider depression as ‘understandable’ and an 
inevitable consequence of ageing. The current study aimed to explore older people’s 
attitudes towards their own ageing and the effect of clinical depression. Twenty eight 
participants over the age of 60 with clinical depression were compared with a control 
sample of non depressed participants. Groups were compared on measures including: 
Attitudes to Ageing Questionnaire, Geriatric Depression Questionnaire, quality of 
life, satisfaction with health and various demographic variables. The clinically 
depressed sample also completed the Geriatric Anxiety Scale, Beck Hopelessness 
Scale, Prospective and Retrospective Memory Questionnaire and the 
Understandability Questionnaire. Results showed significant differences in attitudes 
to ageing relating to psychosocial loss, with the depressed population reporting more 
negative attitudes. Depression was found to be a significant predictor of negative 
attitudes and factors including increased hopelessness and reduced quality of life 
were also associated with negative attitudes. This study highlights the importance of 
assessing attitudes to ageing in older people with depression as this may have 
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Background: Dementia, stroke and Parkinson’s disease (PD) are three common 
neurological conditions in older people. Depression in these conditions significantly 
affects quality of life and exacerbates symptoms of the conditions. There is a need 
for effective psychological treatments therefore this review aims to systematically 
review the evidence for cognitive and behavioural therapies in the treatment of 
depression in these three conditions. Method: A systematic literature search was 
conducted using search engines including Medline, Embase, PsycInfo and CINAHL. 
Inclusion and exclusion criteria are described and included articles were assessed on 
methodological quality. Results: Nineteen studies met the inclusion criteria for this 
review: five studies examining dementia, five examining stroke and nine examining 
PD. Results across the different conditions were mixed. There was higher quality 
evidence for the efficacy of behavioural therapies in people with dementia. The 
evidence for post stroke depression was inconclusive and there is preliminary 
evidence that CBT may be efficacious for people with PD. Conclusions: There is 
currently insufficient high quality evidence for the efficacy of CBT based therapies 
for people with these three neurological conditions. However, the evidence for CBT 
in people with PD, and behavioural therapy for people with dementia is promising. 
Further high quality research is required with longer term follow ups in order to 
determine the efficacy of cognitive and behavioural therapies for people with 
dementia, stroke and PD. 
Keywords: Depression, stroke, dementia, Parkinson’s disease, CBT 
 





Clinical depression in late life is a common condition which affects about 8-16% of 
people over the age of 65 (Blazer, 2003). The prevalence rate increases for people in 
care settings including hospitals and care homes (Jorm, 2000). Rates of depression 
also increase in those with neurological conditions (Rodda, Walker & Carter, 2011). 
As the population of older people grows, there will be an increase in neurological 
conditions such as dementia, stroke and Parkinson’s disease (PD). Despite the 
increased risk of depression, it is often unrecognised and therefore untreated in this 
population. This may be partly due to the challenges in diagnosing depression in 
these conditions, for example, depressive symptoms may be attributed to fatigue or 
reduced concentration resulting from the condition (Raskind, 2008). Comprehensive 
assessment of symptoms might also be further complicated by individuals’ cognitive 
impairments and communication difficulties (Rickards, 2005). Identifying and 
treating depression in these conditions is of increasing importance as depression can 
have a significant effect on the prognosis of the condition and on quality of life of 
patients and their carers (Rickards, 2006). 
  
Treatment of late life depression has largely relied on pharmacological approaches 
(Rodda et al., 2011). However, the problems associated with polypharmacy in older 
people are well documented (Kaufman, 2011). It is therefore important to examine 
the role of psychotherapy for depression in later life. In a systematic review 
examining 112 studies, it was concluded that psychotherapy is an effective treatment 
for depression and it is equally effective in older and younger adults (Cuijpers, van 
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Straten, Smit & Andersson, 2009). NICE (2009) guidelines recommend a 
combination of medication and psychotherapy in the treatment of late life depression.  
 
Among the psychotherapies for older people, cognitive behavioural therapy (CBT) 
has the largest evidence base (Pinquart, Duberstein & Lyness, 2007). It focuses on 
the links among people’s thoughts, feelings and behaviour and it may be particularly 
useful for older people as it is easy to understand, problem focused and skills 
enhancing, and it empowers individuals to develop a range of coping strategies 
(Laidlaw, Thompson & Gallagher-Thompson, 2004). Several systematic reviews and 
meta-analyses have examined the role of CBT for late life depression and concluded 
that it is more effective than treatment as usual, and equally effective to other 
treatments, including pharmacotherapy and other psychotherapies (e.g. Gould, 
Coulson & Howard, 2012).  
 
It has been suggested that CBT may be adapted for use with people with neurological 
conditions (Broomfield et al., 2011). It has already been applied within a range of 
different populations, including people with learning disabilities (e.g. Hassiotis et al., 
2013) and people with long term medical conditions (e.g. Halford & Brown, 2009). It 
has been shown to be effective in reducing depressive symptoms in people with 
physical health conditions, such as cancer and diabetes (e.g. Beltman, Voshaar & 
Speckens, 2010). With regard to neurological conditions, it has been successfully 
used to treat depression in people with multiple sclerosis (e.g. Mohr, Boudewyn, 
Goodkin, Bostrom & Epstein, 2001) and traumatic brain injury (e.g. Fann, Hart & 




Despite evidence suggesting that CBT may benefit people with various neurological 
conditions, there is still a lack of research examining this in older adults. It may be 
that researchers have been reluctant to use CBT with this client group due to the 
cognitive impairments that may make it difficult for people to engage and utilise it 
effectively.  However, CBT can be adapted for people with cognitive impairment 
(Spector et al., 2012), for example, by utilising memory aids, increasing repetition 
and maintaining highly structured sessions (Gellis, McClive-Reed & Brown, 2009).  
 
The most common neurological conditions occurring in older people are dementia, 
stroke and Parkinson’s disease. Given the high rates of depression associated with 
these conditions and the significant impact it can have on clinical outcomes, it is 
important that there are effective treatments for depression. Each of these conditions 
will firstly be outlined separately. 
 
Dementia 
Dementia affects over 800,000 people in the UK (Luengo-Fernandez, Leal & Gray, 
2010) and Alzheimer’s disease (AD) is the most common type of dementia. AD is 
characterised by gradual decline in cognitive functioning. Additionally, psychiatric 
and behavioural disturbances can affect up to 90% of people with AD (Lyketsos & 
Olin, 2002) and 20-25% of people with AD will experience major depression. The 
link between depression and dementia is complex, and although some researchers 
consider depression as a prodrome to dementia (Brommelhoff et al., 2009), the 
presence of dementia also increases the risk of depression (Wilkins, Kiosses & 




Symptoms of depression in dementia, such as apathy, hopelessness and anhedonia 
can have a significant impact on the prognosis of the disease; it exacerbates cognitive 
impairment and has been linked with increased mortality (Sutcliffe et al., 2007). 
Additionally, depression and anxiety have been associated with reduced quality of 
life (Hoe, Hancock, Livingston & Orrell, 2006) and increased risk of admission to a 
nursing home (Gibbons et al., 2002). As well as increasing distress to the individual 
suffering from dementia, depression also increases caregiver distress (Gonzalez-
Salvador, Arango, Lyketsos & Barba, 1999). 
 
With regard to treatment of depression in dementia, there is insufficient evidence that 
antidepressant medication is effective (Bains, Birks & Dening, 2002). The UK 
National Institute for Health Research conducted a large scale RCT examining 
antidepressant medication for depression in dementia and concluded that they are not 
cost effective treatments (Banerjee et al., 2013). They suggested that antidepressants 
should not be prescribed as a first line treatment and that psychosocial interventions 
should be further examined. A range of psychological approaches in addition to CBT 
have been examined, including interpersonal therapy (Burns et al., 2005), and group 
psychotherapy (Cheston, Jones & Gillard, 2003). However, these studies did not find 
significant treatment effects. There is also an increasing recognition of the 
importance in involving carers in treatments (Paukert et al., 2010). 
 
Stroke 
Stroke affects around 130,000 people per year in the UK (National Audit Office, 
2005) and it is most common cause of disability and the third most common cause of 
death in the UK. However, survival rates are increasing and as they do, there will be 
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a greater need for reducing morbidity in survivors. In addition to physical disability 
and cognitive impairments, post stroke depression has been reported to occur in 
about 30 per cent of cases (Kneebone & Lincoln, 2012). Vulnerability to depression 
is increased following stroke due to the nature of the impairments it causes. For 
example, impaired physical functioning can result in a reduced ability to engage in 
pleasurable activities and cognitive deficits can result in negative thinking biases 
(Broomfield et al., 2011). 
  
It is important to assess and treat post stroke depression as it is associated with 
increased cognitive impairment and increased mortality (Williams et al., 2007). It 
also reduces quality of life and increases burden to carers (Kootker, Fasotti, Rasquin, 
van Heugten & Geurts, 2012). There is a lack of research examining the 
effectiveness of psychological treatments for post stroke depression. Hackett, 
Anderson, House and Xia (2008) conducted a systematic review of the effects of 
psychotherapy on post stroke depression and concluded that there are not enough 
studies of good quality to demonstrate any significant benefit of psychological 
treatments. Despite this limited evidence base, researchers have suggested that CBT 
ought to be suitable for people with post stroke depression (Broomfield et al., 2011) 
and therefore further research is needed to examine whether there is evidence for an 
augmented CBT approach in this population. Most of the research to date has 
examined interventions targeting the prevention of post stroke depression (Robinson 
et al., 2008). In particular, motivational interviewing has been shown to reduce the 






Parkinson’s disease (PD) is a degenerative neurological condition characterised by 
motor symptoms such as bradykinesia (slowness of movement), tremors and rigidity 
(Misayaki et al., 2006). As such, simple activities of daily living including walking, 
dressing and eating are more difficult for people with PD. This can have a significant 
impact on an individual’s quality of life and relationships with others. 
 
Non-motor symptoms include neuropsychological symptoms such as cognitive 
impairment (Macht, Pasqualini & Taba, 2007). Depressive symptoms are also 
common, occurring in about 35 per cent of people with PD (Reijnders, Ehrt, Weber, 
Aarsland & Leentjens, 2008). There is debate in the literature as to whether 
depression in PD is ‘reactive’ or ‘organic’, with some researchers suggesting that 
people with PD are more susceptible to depression due to the neuropathological 
changes associated with the condition (Slaughter, Slaughter, Nichols, Holmes & 
Martens, 2001). However, it has been stated that there is little evidence for this 
distinction and that it should not affect treatment choice (Leentjens, 2004).  Similar 
to stroke and dementia, depression in PD has an adverse affect on prognosis of the 
disease and has been associated with a greater decline in cognitive and motor 
functioning as well as poorer quality of life (Menza et al., 2009). 
 
The treatment of depression in PD has largely relied on pharmacotherapy. However, 
there is insufficient evidence that antidepressant treatments are effective in people 
with PD (Burn, 2002; Leentjens, 2004). This is also made more complicated by 
adverse side effects, for example, the risk of falls in PD increases with polypharmacy 
(Ashburn et al., 2001). This highlights the importance of having alternative 
14 
 
interventions for mood disorders in PD (Charidimou, Seamons, Selai & Schrag, 
2011). It has been suggested that psychological therapy such as CBT may be useful 
in the treatment of depression in PD (Cole & Vaughan, 2005). Assogna et al.’s 
(2013) study demonstrated that depressive symptoms in people with PD are 
comparable to those with other non-neurological illnesses, suggesting that people 
with PD could also potentially benefit form CBT. Further research is need, however, 
as a recent Cochrane review examining treatments for depression in PD did not find 
any studies of psychological therapy that were of a good enough quality to include in 
their review (Ghazi-Noori, Chung, Deane, Rickards & Clarke, 2009). 
 
Rationale for current systematic review 
Dementia, stroke and PD are the most common neurological conditions affecting 
older people and there is an increased risk of depression associated with them. 
Depression impairs quality of life and causes excess disability in these conditions. 
Therefore, effective treatments for depression will have a significant impact on the 
overall functioning of people with neurological conditions (Raskind, 2008), thus 
improving health outcomes and lowering treatment costs.  
 
Research to date has shown indications that psychological interventions may be 
effective for people with neurological disorders (e.g. Yang, Sajatovic & Walter, 
2012). In particular, CBT may be particularly suitable for use in the population as it 
is structured, time limited and focuses on the here and now. However, a focused 
review of the role of CBT in treating depression in these conditions has not yet been 
conducted. This will be of relevance for clinicians working in older adult mental 
health services as a high proportion of service users will have will have neurological 
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The aim of this systematic review is to investigate the efficacy of cognitive and 
behavioural therapies for the treatment of depression in people with neurological 




The Cochrane database of systematic reviews (CENTRAL) was searched to ensure 
that there were no existing reviews of this topic. Then OVID databases: Medline 
(1946 - 2013) and EMBASE (1974 – 2013) were searched. The EBSCO databases: 
PsychINFO (to 2013) and CINAHL (to 2013) were also searched.  
 
Search terms included: cognitive therapy, behaviour therapy, cognitive behaviour 
therapy and problem solving therapy. These were used in conjunction with: 
depression or depressive disorder. Each neurological condition was searched for 
separately using the following search terms: stroke or cerebrovascular accident; 
Parkinson’s disease or parkinsonism; dementia or Alzheimer’s disease. Key words 
were identified for each database and the search terms were mapped to a subject 
heading relevant to the particular database. The search engine Google Scholar and 
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Science Direct were also used during the search strategy and the references of 
relevant articles were examined in order to gather further papers. 
 
Inclusion and exclusion criteria 
Inclusion and exclusion criteria were determined based on PICOS criteria, outlined 
in the Centre for Reviews and Dissemination Guidelines (CRD, 2008).  
 
Population 
Studies were selected if they included participants with diagnoses of dementia, stroke 
or PD. In order to ensure that the intervention was effective in a particular condition, 
studies were excluded if they examined participants with more than one neurological 
condition. Although there may be overlap, for example, individuals with vascular 
dementia may also have had strokes, the primary diagnosis was taken into 
consideration. Studies were included if participants had the presence of depression of 
any severity. This was based on either meeting criteria for depression according to 
the DSM-IV or ICD-10. Alternatively, depression could be indicated by use of 
clinical cut-off scores on standardised outcome measures. The review only included 
studies confined to adults (aged 18 or over).   
 
Intervention 
The primary intervention examined is CBT. There are a range of therapies that are 
based on cognitive behavioural principles and can be classed as variations of CBT. 
Thus, therapies including behaviour therapy, cognitive therapy or problem solving 
therapy were also included in this review. Most interventions involved individualised 
CBT, however, telephone CBT, group CBT and computerised CBT (cCBT) 
17 
 




Studies were included if level of depression was an outcome following treatment. 
Studies that did not use standardised outcome measures for assessing depression 
were excluded. Papers that also included other outcomes, for example, anxiety or 
quality of life, were not excluded. 
 
Study design  
Randomised controlled trials (RCTs) were sought as they are generally believed to 
provide the highest quality of evidence when reviewing interventions. However, 
studies using other designs were included if they met the above inclusion criteria, 
such as uncontrolled trials with pre and post measures and case series designs.   
 
Other criteria  
Papers were limited to English language as there were no translation services 
available. It is important to carry out a broad search of literature, both published and 
unpublished. However, due to constraints of this review, only research articles from 
peer reviewed journals were included. Review articles were excluded.  
 
Quality criteria  
Criteria were developed in order to rate the methodological quality of the included 
studies. These criteria were based on the SIGN 50 (2011) guidelines and adapted to 
the needs of the current review question. The PRISMA statement (Liberati et al., 
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2009) for reporting systematic reviews was also consulted. It states that the 
assessment of risk of bias should be addressed using standardised criteria, which may 
need to be adapted depending on the nature of the included studies. The quality 
























Table 1.1: Quality Criteria 
 
Quality Criteria Description Rating 
1. Study design 
Experimental 
RCT 
Well covered (3) 
Experimental 
Non randomised controlled trial 
Adequate (2) 
Observational 




Very Poor (0) 
2. Clearly focused and 
appropriate research 
question(s) 
Question(s) clearly focused and  
appropriate 
Well covered (3) 
Question(s) adequately focused and 
appropriate 
Adequate (2) 
Question(s) poorly defined or 
inappropriate 
Poor (1) 
No research question(s) described Not addressed (0) 
3. Population 
appropriate and clearly 
described using 
inclusion and exclusion 
criteria 
Population clearly appropriate to 
research question e.g. clear 
diagnosis of depression and 
neurological  condition 
Well covered (3) 
Population adequately appropriate 
to research question 
Adequate (2) 
Population inappropriate or poorly 
described 
Poor (1) 
Population not addressed Not addressed (0) 
4. Appropriate and 
clearly randomised 
control group 
Random allocation, investigator(s) 
blinded, treatment and control 
groups comparable at start of trial 
Well covered (3) 
Control group adequately 
randomised or groups not 
comparable 
Adequate (2) 




No control group 
 
Not addressed (0) 
20 
 
5. Intervention clearly 
described to ensure 
reliability and external 
validity of therapy 
Intervention clearly described, 
treatment protocols followed which 
are replicable. Study ensures 
external validity of therapy. 
Well covered (3) 
Intervention adequately described 
or no treatment protocols used. 
Adequate (2) 
Intervention poorly described or 
poor validity of therapy. 
Poor (1) 
Intervention not described or 
inappropriate intervention used. 
Not addressed (0) 
6. Intervention 
appropriately conducted 
to ensure internal 
validity and treatment 
fidelity 
Intervention appropriately carried 
out by a suitably trained 
professional, and attempts made to 
ensure treatment fidelity (e.g. 
monitoring to ensure therapy 
administered accurately and 
consistently) 
Well covered (3) 
Intervention not carried out by 
trained professional and only 
adequate attempts to ensure fidelity. 
Adequate (2) 
Intervention not carried out by 
trained professional or no attempts 
made to ensure fidelity 
Poor (1) 
Information on therapist(s) or 
treatment fidelity not provided 
Not addressed (0) 
7. Use of appropriate 
and standardised 
outcome measures that 
are valid and reliable for 
measuring depression 
All depression outcome measures 
appropriate, valid, reliable and 
standardised 
Well covered (3) 
Most (more than 50%) depression 
measures are appropriate and 
standardised. 
Adequate (2) 
Some (less than 50%) depression 
measures appropriate and 
standardised 
Poor (1) 
Inappropriate depression measures 
used 
Not addressed (0) 
8. Appropriate and 
clearly reported 
statistical analysis 
Appropriate and clearly reported 
statistical analysis 
Well covered (3) 
Appropriate and adequately 
reported statistical analysis 
Adequate (2) 
Inappropriate or poorly conducted 
statistical analysis 
Poor (1) 
Statistical analysis not carried out 
or not reported. 
Not addressed (0) 
9. Follow up measures 
administered 
Follow up measures > 12 months Well covered (3) 
Follow up measures > 6 months Adequate (2) 
Follow up measures < 6 months Poor (1) 






Study Inclusion  
The search strategy yielded 525 results. The titles and abstracts of these studies were 
screened and those that were irrelevant were excluded. This resulted in a total of 89 
studies remaining. Full copies of these papers were analysed using the inclusion and 
exclusion criteria. Duplicates were removed and further articles were removed as 




The quality criteria outlined in Table 1.1 were applied to each of the studies. In order 
to increase confidence in the ratings, each paper was co-rated by a Trainee Clinical 
Psychologist. Agreement (within two marks) on the total quality score was found for 
14 out of 19 (74%) of the co-rated papers. Disagreement by three marks was found 
for four of the papers, and one paper’s ratings disagreed by four marks. All 
disagreements were reviewed through discussion and ratings were amended to the 
consensus.  
 
The total quality score that studies could receive was 27. There is evidence that 
numerical ratings of quality can be misleading when conducting systematic reviews 
(Liberati et al., 2009) therefore the studies were also categorised into qualitative 
ratings: Poor (0-14), Good (15-20), Excellent (21-27). The ratings for each of the 








Studies identified by search strategy 
PsychInfo (n=87); Medline (n=124); 
Embase (n=239); Cinahl (n=75) 
Total N=525 
Full copies obtained for 
assessing eligibility 
N = 89 
Total selected and 
included in current review 
N=19 
Studies deemed irrelevant and 
excluded on the basis of title 
and abstract 
PsychInfo (n=59); 
Medline (n=104);  
Embase (n=210);  
Cinahl (n=60) 
Total Excluded (N = 433) 
 Duplicates removed (N = 40) 
More studies added from 
Google Scholar search 
 (N = 2)  No diagnosis of depression 
(n=7); 
No diagnosis of neurological 
condition (n= 7); 
Not using CBT (n= 4); 
Protocol only (n=4); 
Review article (n=7); 
Co-morbidity of conditions 
 (n= 2); 
Caregiver intervention (n= 1)  




General characteristics of studies 
 
The general characteristics of the included studies are described in Table 1.2.  In the 
19 studies admitted into this review, there were seven RCTs, four uncontrolled trials 
and eight case series designs, all meeting quality and inclusion criteria. With regard 
to the neurological conditions examined, five studies included people with dementia, 
five included people who had experienced a stroke, and nine studies included people 
with PD.  
 
Most of the studies examined individualised CBT, however, two papers examined 
telephone-delivered CBT for people with PD (Dobkin et al., 2011b; Veazey, Cook, 
Stanley, Lai & Kunik, 2009). One study examined group CBT for people with PD 
(Feeney, Egan & Gasson, 2005). Five of the studies focused on behavioural 
interventions (Kiosses, Arean, Teri & Alexopoulos, 2010; Mitchell et al. 2009; 
Snarski et al., 2011; Teri, Logsdon, Uomoto & McCurry, 1997; Thomas, Walker, 

































Quality score and 
qualitative rating 
Dementia          








HAM-D N = 15 (mean 




mean age 78) 
 
None  PST was significantly 














GDS-30 N = 7 (mean 
age 72)      
None None Statistically significant 
decrease in mean GDS-
30 scores. Two of the 













GDS-15 N = 25 (mean 
age 71) 
TAU (n = 25; 
age >65) 
None 24% of the BA group 
showed clinically 
significant reduction in 
GDS-15 scores, 
compared with 12% of 
controls. 
Excellent (21) 

















mean age 72) 
Typical care 
control (n= 10; 
mean age 79) 
Wait list 
control (n = 
20; mean age 
76)  
6 months  A significant treatment 
effect was found on all 
depression measures and 
effects were maintained 
































N = 1 (age 
75) 
None 1, 3, 6, 
and 12 
months 
There was an 
improvement in all 
measures following 
therapy. This was not 
assessed statistically.  
Poor (13) 














placebo (n = 
43; mean age 
66) 
Standard care  
(n = 41; mean 
age 65) 
3 and 6 
months  
There was an 
improvement in mood 
after 6 months but there 
were no significant 
differences between the 
three groups.  
Good (20) 
















N= 19  
(mean age 
67) 
None None Significant decrease in 
BDI scores following 
CBT. Improvement as 
measured by the HADS 

















N = 47  
(mean age 
57) 
TAU (n = 53; 
mean age 57)  
9 weeks, 
6, 12 and 
24 months   
Behavioural intervention 
with antidepressant was 
more effective at 





















Quality score and 
qualitative rating 















N = 5  
(mean age 
46) 
None 1 and 3 
months 
CBT was found to be 
acceptable and feasible. 
Three of the five 
participants showed 
significant improvements 
on the BDI-II 
Poor (12) 
















N= 51  
(mean age 
68) 
TAU (n = 54; 
mean age 65)  
3 and 6 
months 
BT improved mood. The 
treatment group made 
significantly greater 
reductions in SADQ 
scores than the control 
group, which were 






















There was a clinically 
significant reduction in 
GDS-15 scores for 4 
patients and a reduction 
in BDI-II scores for 2 
patients. 
Poor (12) 




Case series CBT  
(12 – 14 










All three patients 
observed a clinically 
significant decrease in 
depression scores (up to 



















Quality score and 
qualitative rating 






after study)  
CBT  
(10-14 











Significant decrease in 
BDI and HAM-D scores 
(a mean reduction of 10 
points on each measure).  
Good (20) 



















Significant reductions in 
HAM-D (mean reduction 
of 7 points) and BDI 
scores in CBT group 
compared to control 
group 
Excellent (25) 




















Significant decrease in 
HAM-D (mean reduction 













N = 8  
(mean age 
63) 
None None   Statistically significant 
decrease in HAM-D 
scores (mean reduction 
of 9 points). Following 






















Quality score and 
qualitative rating 




Case series  Group CBT 











improvement on BDI-II 








Case study CBT  
(7 sessions 





N = 1  
(age 84) 
None None Pre and post measures 
revealed no change on 














 (mean 8 
sessions with 
psychologist) 




support (n = 5; 
mean age 75) 
One 
month 
Feasibility of telephone 
CBT was suggested but 
there was no significant 
differences found 
between CBT and 
support conditions.  
Poor (11) 
 
Abbreviations: BA: behavioural activation; BDI = Beck Depression Inventory; BT: behaviour therapy; CBT: cognitive behaviour therapy, 
CLCE-24: Checklist for cognitive and emotional consequences following stroke; CORE-10: Clinical Outcomes Routine Evaluation Scale 
CSDD: Cornell Scale for Depression in Dementia; GDS  Geriatric Depression Scale; HADS: Hospital Anxiety and Depression Scale; HAM-D: 
Hamilton Rating Scale for Depression; HANDS: Harvard National Depression Screening Day Scale; PHQ-9: Patient Health Questionnaire-9; 
PST = problem solving therapy; RCT: Randomised Controlled Trial; SADQ: Stroke Aphasic Depression Questionnaire; SLC-D: Symptom 





Table 1.3. Quality ratings for included studies.  
 


















Adequate Well covered 
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Veazey et al. 
(2009) 






For clarity of presentation, the evidence for CBT based therapies in each of the 
neurological conditions will be examined separately below. It is useful to delineate 





The sample sizes of the experimental groups ranged from 1 to 42 participants. The 
mean ages of the participants ranged from 71 to 80 years. Four of the studies 
included people with major depressive disorder which was assessed using DSM-IV 
or ICD-10 criteria. One study (Snarski et al., 2011) comprised participants with mild 
depression which was rated using the GDS-15.  
 
Intervention 
Two studies (Scholey & Woods, 2003; Walker, 2004) carried out CBT in a case 
series format. The remaining three studies were RCTs and they carried out behaviour 
therapy (Teri et al., 1997), behavioural activation (Snarski et al., 2011) and problem 
solving therapy (Kiosses et al., 2010). The interventions were carried out by various 
professionals including a geriatrician, a psychologist, and graduate psychology 
students. The mean number of sessions ranged from 8 to 16. Follow up measures 








All of the studies used standardised outcome measures of depression, including the 
HAM-D and the GDS. Two studies used the CSDD which is specifically designed to 
assess for depression in people with dementia.  
 
Results 
All five studies reported positive effects of the interventions in terms of reducing 
depressive symptoms. The three studies that were rated highly on methodological 
quality were RCTs evaluating behavioural therapies. Overall, they reported 
significant differences between treatment and control groups. Teri et al. (1997) found 
large effect sizes and reported that 60 per cent of the participants in the treatment 
conditions no longer met criteria for depression after six months, compared with 20 
per cent of the control participants. Kiosses et al. (2010) noted that the problem 
solving therapy was significantly more effective than supportive therapy at reducing 
depressive symptoms. Snarksi et al. (2011) showed that for people with mild 
depression, behavioural activation was more effective than treatment as usual. They 
reported that 24 per cent of the treatment group demonstrated a clinically significant 
change, compared with 12 per cent of the control group.  
 
Two papers which used case series or case study designs and were rated lower in 
methodological quality (Scholey & Woods, 2003; Walker, 2004) reported positive 
effects of CBT. Scholey and Woods (2003) described a series of eight patients, all of 
whom showed improvements in depression levels, however, only two of them 
showed change at a level of clinical significance, as measured by the Reliable 




In summary, it appears that there is evidence for behavioural therapies in treating 
depression in people with dementia, as provided by three RCTs.  However, despite 
their robust methodologies, firm conclusions cannot be drawn as there was a lack of 
consistency regarding the content and delivery of the interventions, the outcome 
measures used and the homogeneity of the participants. With regard to CBT, it is 
suggested that it may reduce depressive symptoms, however, the evidence to date has 
relied on studies of case series design and CBT has not yet been examined 





Across the five studies examining BT or CBT for depression following stroke, 
sample sizes ranged from 5 to 51. The mean ages of the participants ranged from 46 
to 68 years. Three studies were RCTs with control groups who received treatment as 
usual (Mitchell et al., 2009; Thomas et al., 2012) or an attention placebo (Lincoln & 
Flannaghan, 2003). Therapy was conducted with participants who had experienced 
strokes between 1 and 10 months prior to the intervention. Two studies used DSM-
IV or ICD-10 criteria for ensuring diagnoses of depression. Three studies used 
standardised outcome measures to determine the presence of depression. 
 
Intervention 
Three of the studies examined CBT (Lincoln & Flannaghan, 2003; Lincoln et al., 
1997; Rasquin et al., 2009) and the remaining two examined behavioural therapy 
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(Mitchell et al., 2009; Thomas et al., 2012). The mean number of sessions ranged 
from 8 to 10. There was variation in the professional background of the therapists, 
for example, in two RCTs, the intervention was conducted by Community 
Psychiatric Nurses (CPNs) (Lincoln & Flannaghan, 2003; Mitchell et al., 2009). In 
the other studies, the therapy was conducted by Clinical Psychologists or Assistant 
Psychologists. All but one study (Lincoln et al., 1997) included follow up measures, 
ranging from 3 to 24 months.  
 
Outcome measures   
All of the studies used more than one standardised outcome measures of depression. 
The most commonly used outcome measure was the BDI. Two studies also used 
measures specifically designed for assessing depression in people who have 
experienced stroke (CLCE-24: Rasquin et al., 2009; SADQ: Thomas et al., 2012). 
 
Results 
Among the highest quality studies, an RCT examining CBT by Lincoln and 
Flannaghan (2003) reported no significant differences between the treatment 
condition and the two control conditions (treatment as usual and an attention 
placebo) on any depression measures. Whilst relatively highly rated, several factors 
may have influenced the null effect. For example, both the intervention and the 
control conditions were delivered by a CPN whose level of training was not 
adequately described. Additionally, there was little attempt to ensure treatment 
fidelity such as ensuring supervision was provided and treatment protocols were 
adhered to. A good quality pilot study by Lincoln et al. (1997) examined CBT in 19 
people with stroke and found an overall significant decrease in BDI scores following 
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therapy. However, no significant differences were found on the other depression 
outcome measures, namely the HADS and WDI. 
 
There were two RCTs, also rated highly on quality that examined behavioural 
interventions (Mitchell et al., 2009; Thomas et al., 2012). These studies reported that 
both treatment and control groups improved over time, however, the treatment 
groups made significantly more improvements. Mitchell et al. (2009) also carried out 
longitudinal follow ups and found that remission rates continued up to rise up to two 
years after therapy. After 12 months the treatment group demonstrated significantly 
more remission (48%) compared with the control group (27%). At 24 months, the 
remission rate rose to 65%, however, at this time the difference between groups was 
no longer significant.  
 
A case series by Rasquin et al. (2009) was rated as poor on methodological quality. 
This study found that three of the five presented cases showed clinically significant 
improvements in BDI-II scores. 
 
In summary, results among the five post stroke studies were mixed. All of the studies 
reported reductions in depressive symptoms over time, however, differences were 
not always found between treatment and control groups (Lincoln & Flannaghan, 
2003). Of the available evidence, it currently appears that behavioural therapies may 
be more effective than CBT for treating depression in people with stroke, reasons for 





Parkinson’s disease (PD) 
 
Participants 
The sample sizes of the studies ranged from 1 to 41 and the mean ages of the samples 
ranged from 63 to 84 years. Two of the nine studies included a control group 
receiving clinical monitoring (Dobkin et al., 2011a) or telephone support (Veazey et 
al., 2009).  Seven studies included participants diagnosed with depression according 
to DSM-IV criteria whereas two studies used standardised outcome measures such as 
the PHQ-9 and the GDS in order to determine criteria for depression. 
 
Intervention  
In all nine studies, CBT was the treatment used, however, two studies examined 
telephone CBT (Dobkin et al., 2011b; Veazey et al., 2009) and one study examined 
group CBT (Feeney et al., 2005). In all studies, the interventions were carried out by 
Clinical Psychologists. The number of sessions provided ranged from 7 to 14. Seven 
studies administered follow up measures after one month and the remaining two did 
not take follow up measures (Farabaugh et al., 2010; Richardson & Marshall, 2012).  
 
Outcome measures  
Standardised outcome measures of depression were used in all studies: five studies 
used the HAM-D; six used the BDI; two used the GDS and one used the PHQ-9. 
 
Results 
The methodologically stronger studies demonstrated efficacy of CBT for depression, 
reporting mean reductions in HAM-D scores ranging from 7 to 10 points, which 
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were shown to be statistically and clinically significant (Dobkin et al., 2007; Dobkin 
et al., 2011a; Dobkin et al., 2011b). Dobkin et al.’s (2007) trial reported that 80 per 
cent of PD patients experienced significant reductions in depressive symptoms. 
Despite lacking a control group, this study was well conducted and provides a 
compelling suggestion that CBT is effective for people with PD. Following from this 
study, Dobkin et al. (2011a) conducted an RCT which replicated the previous 
positive findings. Significant differences in depressive symptoms between the 
treatment and control group were reported (mean HAM-D reductions of 7 and 0 
respectively). Dobkin et al. (2011b) also noted that telephone CBT may be useful for 
this population due to the likelihood of physical disability which may make 
travelling to a clinic more difficult. In their uncontrolled trial, they reported 
significant reductions in depressive symptoms following telephone CBT.  
 
Five studies, rated lower in quality, used case series designs. Together, they 
contained a total of 21 participants and overall, symptoms of depression reduced 
following therapy. However, two of these studies reported mixed results. For 
example, Richardson and Marshall (2012) found that although participants’ scores 
improved on the GDS-15 and CORE-10, there was no change on the HADS pre and 
post therapy. Similarly, Cole and Vaughan (2005) found a reduction in GDS-15 
scores in four of the five participants, but only two participants showed clinically 
significant reductions in BDI-II scores. Although these outcome measures are valid 
and standardised for use with the general population, it is important to consider their 
differences and determine the most appropriate measures for using with people with 
PD. Another lower quality study (Veazey et al., 2009) compared telephone CBT with 
telephone support and in contrast to the positive results found by Dobkin et al. 
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(2011b), they found no significant differences between groups. However, this study 
lacked clarity on the content and delivery of the intervention therefore making it 
difficult to ensure that the CBT was appropriately conducted. Additionally, their 
sample comprised male veterans and is therefore not representative of the population 
of people with PD.  
 
In summary, three higher quality studies and five lower quality studies all reported 
positive effects of CBT in the treatment of depression and one study (Veazey et al., 
2009) found no effect of CBT. Although it has been shown that CBT may reduce 
depressive symptoms, many of the included studies did not have control groups and 
the longest length of follow up was only one month. Nevertheless, there is 
compelling preliminary evidence that CBT may be beneficial for people with PD and 
this should be examined further by RCTs which include longitudinal follow ups.  
 
Overall Results  
Three neurological conditions were examined in this systematic review, which 
included five papers examining dementia, five examining stroke and nine examining 
PD. Across all conditions, there are suggestions that CBT based interventions are 
feasible and effective for the treatment of depression. With regard to dementia, there 
is a lack of evidence for the effectiveness of CBT, though there is more robust 
evidence for the role of behavioural therapies and adaptations of CBT including 
problem solving therapy. Similarly, within the stroke literature, there is insufficient 
evidence for CBT, however, more promising evidence for the role of behavioural 
interventions. Compared with dementia and stroke, there has been more research 
examining CBT for people with PD. There was also less variability within the PD 
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studies included in this review. For example, all nine studies examined CBT, their 
interventions were similar in terms of number and duration of sessions, content of 
sessions and therapists’ level of training (all Clinical Psychologists). There is good 
preliminary evidence to suggest that CBT for depression for people with PD may be 
effective, however five of the studies were case-series and none of the studies 




The aim of this systematic review was to examine the evidence for cognitive and 
behavioural therapies in the treatment of depression in neurological conditions 
common in older adults. Overall, there are some consistent findings suggesting that 
CBT and behaviourally based approaches may be effective in the reduction of 
depressive symptoms. However, to date there has been little attention paid to this 
area of research and as such, the available evidence is preliminary. 
 
Methodological Limitations in Reviewed Literature 
There are a number of methodological limitations which must be taken into 
consideration when examining the results of the studies included in this review. 
There was heterogeneity regarding the interventions, including the number and 
duration of sessions. For example, most provided an average of 8 to 10 sessions. 
CBT can typically require 16 to 20 sessions, particularly for moderate to severe 
depression (NES, 2011). This may also be the case for people with neurological 
conditions as individuals’ cognitive impairment may necessitate a slower pace of 
therapy with more repetition. Some of the papers included in this review noted in 
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their discussions that the ‘dose’ of therapy might not have been enough to show 
significant changes (Lincoln & Flannaghan, 2003).  
 
The studies also varied in content and delivery of the interventions. Many studies 
only partially addressed treatment fidelity, for example, ensuring protocols were 
followed and that therapists received supervision. In clinical practice it may be that 
therapists work eclectically, and indeed a core component of CBT is an idiosyncratic 
formulation thus requiring a degree of adaptation. However, it has been suggested 
that for research purposes, consistency and structure is needed in order to ensure 
validity and reliability and therefore accurately assess efficacy of treatment (Firth, 
2013). 
 
The use of outcome measures also varied. Some studies only used one measure of 
depression and of those that used more than one, some studies found mixed results 
depending on which outcome measure was used. Additionally, ten studies used the 
BDI, which has been reported to be confounded by medical illnesses due to its 
presence of somatic symptom items (Thombs et al., 2010). Therefore, the BDI may 
not be the most appropriate measure for using with older people with neurological 
conditions, many of whom will be more likely to have co-morbid physical 
symptoms. Results from self report questionnaires can also be confounded by 
cognitive impairment therefore some studies, examining stroke and dementia, used 
objective measures specifically designed for these populations. The studies 
examining PD did not use outcome measures specifically designed for people with 
PD and it has been suggested that measures such as the Montgomery-Ashberg 
Depression Rating Scale (MADRS; Snaith, Harrop, Newby & Teale, 1986) are used 
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to assess for depression in PD (Yang et al., 2012). Additionally, it has been 
suggested that higher cut off scores in standardised outcome measures could be used 
to assess for depression in people with PD (e.g. Visser, Leentjens, Marinus, 
Stiggelbout & van Hilten, 2006). 
 
There are various other methodological design issues that may affect the quality of 
the evidence for CBT based therapies in the three neurological conditions. Eight 
studies used case series designs, which are considered as poor quality evidence due 
to the high risk of author bias. Small sample sizes also reduce generalisability of 
results. Longitudinal follow up data is important to gather when conducting research 
examining efficacy of interventions. Only two studies reported follow up information 
longer than 12 months: in the case study by Walker (2004) lasting treatment effects 
were reported at 12 months but in an RCT by Mitchell et al. (2009), no significant 
differences were found between groups after 24 months. Further research with long 
term follow-ups will help clarify whether outcomes are maintained and provide 
important information on cost effectiveness. It may be particularly interesting to 
examine this in people with neurological conditions, as some of these conditions will 
be progressive.  
 
Clinical Implications  
There are important clinical implications with regard to providing psychological 
therapy to older people with neurological conditions. Given their increased risk of 
depression and the significant effects that depression can have on the prognosis of 
the neurological condition, it is essential to find effective treatments. Often, there are 
more complications associated with anti-depressant medication in this population, 
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therefore psychological therapies such as CBT have the potential to be applicable 
and beneficial.  
 
CBT versus Behaviour Therapy 
From the results of this systematic review, there appears to be stronger evidence for 
the role of behavioural interventions than CBT in treating depression amongst those 
with dementia or stroke. Nevertheless, there is evidence indicating that CBT enables 
reductions in depressive symptoms amongst those with PD, at least at one month 
post intervention. Several reasons may account for this. Firstly, design issues and 
heterogeneity of the interventions may have affected the results. There was less 
variation among the PD papers and the CBT was conducted by Clinical 
Psychologists. Whereas the studies examining CBT for people with stroke and 
dementia, the training of the therapist and the use of a treatment protocol was not 
always clear. 
 
Secondly, researchers may have defaulted to examining the role of behavioural 
therapies in people with dementia and stroke. Participants with these conditions were 
more likely to have cognitive impairment, therefore, it may be that behavioural 
interventions were easier to implement and for participants to understand. Within the 
stroke literature, effectiveness of CBT has not been fully demonstrated. However, in 
the research studies, CBT was not adapted to account for cognitive deficits and it has 
been suggested that augmented CBT that is individualised for post stroke depression 
ought to be more effective (Broomfield et al., 2011). CBT has yet to be fully 




Thirdly, some researchers have suggested that CBT is no more effective than its 
behavioural components alone and have thus questioned the need for cognitive 
modifications (Longmore & Worrell, 2007). This, however, is still up for debate and 
the underlying mechanisms of change in CBT remain unclear (Hoffman & Smits, 
2008).  
 
Strengths and limitations of current review 
In contrast to previous reviews examining psychological therapies for people with 
conditions including dementia (e.g. O’Connor, Ames, Gardner & King, 2009), this 
review is the first to focus on the role of CBT in the treatment of depression. It is also 
beneficial to obtain an overarching view of the evidence for a range of neurological 
conditions. Another strength of this review is that the papers were rated 
independently by two reviewers in order to increase reliability of the quality ratings.  
 
This review is limited by the fact that only published studies were included and they 
were limited to papers written in English. Publication bias is a common limitation 
when conducting systematic reviews (Parekh-Bhurke et al., 2011). However, the 
current review did include several high quality papers that reported non-significant 
findings. Another limitation is that the inclusion and exclusion criteria, which 
attempted to reduce heterogeneity and increase ability to compare papers, may have 
excluded potentially informative research papers. 
 
Future research  
The emerging evidence for CBT based therapies for people with neurological 
conditions suggests that BT may be efficacious for dementia and CBT may be 
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efficacious for people with PD. Insufficient evidence was found for CBT for post 
stroke depression. However, it would be hypothesised that CBT would be effective 
for post stroke depression if CBT has shown efficacy for people with dementia and 
PD, given that there are many similarities among these three conditions.  
 
Further research should include control conditions receiving alternative supportive 
therapies will also help to ascertain whether there are effects of CBT or whether 
effects are due to non specific factors such as the therapeutic relationship. 
Longitudinal follow ups are also essential to determine efficacy over time. Further 
research could focus on ascertaining how much CBT is affected by mild cognitive 
impairment. Many of the interventions in the included studies were adapted to suit 
the needs of the client group. It will be worth determining if and what adaptations are 
required when conducting therapy with people with neurological conditions.  
 
Overall conclusions  
In summary, this systematic review has collated the evidence for the efficacy of CBT 
based interventions in the treatment of depression in people with dementia, stroke 
and PD. The evidence to date suggests that behavioural therapies are efficacious in 
the treatment of depression in dementia and that CBT may be efficacious for people 
with PD. The evidence for CBT in post stroke depression is currently insufficient, 
therefore, further research is needed. The available research has several 
methodological limitations and as such, further high quality randomised controlled 
trials are required. Despite this, there are preliminary indications that CBT based 
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Chapter 2: Extended Methodology 
 
This chapter presents an extended outline of the methodology, including the design, 
the participants, ethical considerations, the measures used, and an overview of the 




This study used a cross-sectional design in order to explore attitudes to ageing in a 
clinically depressed older adult population. Between subjects analyses were carried 
out to compare the clinically depressed group with non depressed controls, and 
correlational analyses were conducted to determine associations among the measures 




The study comprised two groups of participants: a clinically depressed group and a 
control group.  
 
Clinically depressed group 
Inclusion criteria were: aged over 60 years, a diagnosis of depression and a score of 
five or above on the GDS-15. Participants were also receiving care from a 
community mental health team (CMHT). Exclusion criteria were: a diagnosis of 
dementia or other cognitive impairment, substance misuse and psychosis. 
Participants were recruited through clinicians working in CMHTs, including: 
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Clinical Psychologists, CPNs, OTs, Social Workers, Support Workers, Guided Self 
Help Workers and Psychiatrists. Clinicians then offered questionnaire packs to all 
patients on their caseloads who met the inclusion and exclusion criteria. 
Questionnaire packs included a participant information sheet (Appendix 6), seven 
self report questionnaires and a stamped addressed envelope to return the 
questionnaires to the researcher anonymously. Potential participants were advised to 
read the information sheet if they were interested in taking part, and if so, complete 
the questionnaires and return to the researcher anonymously. In total, 220 
questionnaire packs were distributed to clinicians working in NHS Highland and 150 
were distributed to clinicians working in NHS Grampian.  In total, 31 questionnaire 
packs were returned. It was not possible to determine how many packs clinicians 
handed out therefore an accurate response rate was not calculated. Of the 31 packs 
returned, three participants scored under five on the GDS-15 therefore, they were 




The sample of control participants was accessed through existing data held from a 
sample of healthy older adults in the community, who participated in the 
WHOQOL/AAQ field trial (Laidlaw et al., 2007). Control participants had already 
completed measures including the AAQ, the GDS-30 and a demographic 
questionnaire. They also answered two additional questions: Rate quality of life (1-5) 
and rate satisfaction with health (1-5). Their scores on the GDS-30 were pro-rated to 
correspond with the scores on the shorter GDS-15. This was done by removing 
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responses from 15 of the questions on the GDS-30. The remaining 15 questions were 
identical to those in the GDS-15. 
 
Within the control sample, there were 15 participants who scored above five on the 
GDS-15, indicating depressed mood. These participants were removed for the initial 
comparison between clinically depressed and non depressed participants. They were 
included again for the correlational analyses examining level of depression and 




Ethical approval was granted by the North of Scotland Research Ethics Committee 
(Appendix 3). Approval was also granted by the Research and Development 





This study only included participants who were able to provide informed consent to 
take part. Each potential participant was provided with an information sheet and had 
the opportunity to contact the researcher with any questions. Since participants were 
provided with questionnaire packs and were able to return them anonymously, 
informed consent was assumed by the returning of the completed questionnaires. 
Undue pressure to participate was reduced as neither the researcher nor the clinicians 
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who distributed the packs were aware as to whether or not their patients returned the 
questionnaires. 
 
Potential distress to participants  
It was acknowledged that some of the participants may have found some of the 
questionnaires distressing as they were asking about their emotions. Participants 
were aware that they did not have to answer all of the questions and they were able to 
stop at any time. All participants had a clinician in the CMHT involved in their care 
and they were encouraged to contact them if they were to become distressed.  
 
Confidentiality 
All results were anonymous therefore no patient identifiable information was stored 
as part of this study, ensuring confidentiality. Questionnaire packs that were returned 





Information was collected by means of a questionnaire on: age, gender, marital 
status, employment status, living arrangements, educational level and health status. 
Participants also completed two questions rated on a 5-point Likert scale: rating 






Attitudes to Ageing Questionnaire (AAQ; Laidlaw et al., 2007) 
The AAQ was developed in collaboration with the World Health Organisation 
(WHO) as part of an international project on the development of Quality of Life 
measures for use with older adults. The AAQ comprises 24 self report items which 
incorporate the concepts of both losses and gains with regard to ageing. Factor 
analysis and structural equation modelling were used during the development of the 
AAQ and three distinct subscales were determined: (1) Psychosocial Loss; (2) 
Physical Change; and (3) Psychological Growth. The psychosocial loss subscale 
measures the negative experiences of ageing in relation to psychological and social 
loss. Physical change relates to the experience of ageing in terms of physical health. 
Psychological growth focuses on the positive aspects of ageing and could be 
summarised as ‘personal wisdom’.  
  
The AAQ contains questions relating to general attitudes about ageing and also 
questions that relate to a more personal experience of individuals’ own ageing. The 
AAQ has several advantages over previous scales. For example, it was specifically 
designed for use with older people, it has been tested in large samples worldwide, 
and provides an insight into the subjective experience of ageing, both positive and 
negative.  
 
The 24 items of the AAQ scale are scored on a 5-point Likert scale (rated from 1= 
strongly disagree to 5= strongly agree). Scores are totalled and higher scores indicate 
more positive attitudes to ageing. The minimum score is eight (strongly disagree with 




Geriatric Depression Scale – short form (GDS-15; Sheikh & Yesavage, 1986) 
The GDS-15 is a widely used standardised measure that was designed for assessing 
depression in older adults. It is a short version of the 30-item Geriatric Depression 
Scale (GDS-30; Yesavage et al., 1983). Responses are entered as ‘yes’ or ‘no’ and 
item scores are totalled to give a minimum of zero and a maximum score of 15. A 
score of five or above is used as a cut off score to indicate the presence of 
depression. It has demonstrated high internal reliability (Cronbach alpha 0.75) and 
good construct validity (Friedman et al., 2005). 
 
Geriatric Anxiety Inventory – short form (GAI-SF; Byrne & Pachana, 2011) 
The GAI-SF is a 5-item self report measure of anxiety. It was designed to be a 
shorter version of the full 20-item GAI and has demonstrated validity and internal 
consistency (Cronbach’s alpha 0.81). The GAI-SF is not affected by age and it is 
recommended for use in research studies.  
 
World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF; WHO, 
1996)   
The WHOQOL–BREF assesses quality of life in four domains: physical health, 
psychological health, social relationships and environment. It comprises 26 self 
report items. It was developed as a shorter version of the 100-item WHOQOL 
measure and has shown good internal consistency with Cronbach’s alpha ranging 
from 0.62 to 0.82 for the four domains (Skevington et al., 2004). Scores on the 
WHOQOL-BREF are transformed to scores between 0-100 in order to correlate with 
the WHOQOL-100. Higher scores indicate higher perceived quality of life. The 
WHOQOL-BREF is suitable for use with older adults (Lucas-Carrasco et al., 2011).  
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Prospective and Retrospective Memory Questionnaire (PRMQ; Smith et al., 2000) 
The PRMQ is a 16-item self report measure that assesses an individual’s subjective 
memory. It comprises eight items that measure prospective memory, for example, 
‘Do you decide to do something in a few minutes’ time and then forget to do it?’ and 
eight items that measure retrospective memory, for example, ‘Do you forget 
something that you were told a few minutes ago?’. Each item is rated on a five point 
scale (very often, quite often, sometimes, rarely, never). Each item is given a score 
between one and five therefore the total scores range from 16 – 80. The PRMQ 
provides a good measure of everyday memory problems and Crawford et al. (2003) 
demonstrated its reliability (Cronbach’s alpha .89). Additionally, the PRMQ is not 
affected by age or gender.   
 
Understandability Questionnaire (Law et al., 2010) 
The understandability questionnaire was developed to measure the extent to which 
people endorse the ‘understandability phenomenon’. It comprises three attitudinal 
statements to which respondents rate their agreement on a 7-point Likert scale. The 
first statement addresses the belief that depression is understandable in old age; the 
second statement reflects the belief that depression is normal in old age, and the third 
statement addresses low expectations of effective treatments of late life depression. 
Lower scores indicate a greater belief that depression is a normal consequence of old 
age.  
 
Beck Hopelessness Scale (BHS; Beck & Steer, 1988) 
The BHS is a measure of hopelessness, in terms of measuring people’s negative 
attitudes. It measures three aspects of hopelessness: feelings about the future, loss of 
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motivation and expectations. It comprises 20 items which are rated true or false. 
Scores are summed giving a total score ranging from 0 – 20. The BHS has 
demonstrated internal reliability (Cronbach’s alpha 0.88) in non clinical samples 
(Steed, 2001).  
 
Analyses, statistical power and sample size calculation 
 
Seven hypotheses were tested in this study and the analysis used for each is 
presented. SPSS version 19.0 was used to conduct the analyses.  
 
Hypothesis 1: The clinically depressed sample will have significantly more negative 
attitudes to ageing on the Psychosocial Loss subscale compared to the non depressed 
control sample.  
 
A one way ANOVA was used to compare the clinically depressed group with the 
non depressed control group on the AAQ. G*Power (Faul et al., 2007) was used to 
determine a sample size. Based on a moderate-large effect size (as evidenced in 
similar studies using the AAQ), with power at 0.8 and alpha at 0.05, G*Power 
estimated that 32 participants would be required in each group. An ANCOVA was 
considered to compare groups while controlling for variables that may be influencing 
AAQ scores. However, significant differences were found between groups on the 
variables that correlated with the AAQ therefore violating the assumption that the 
covariates are independent of the experimental effect (Field, 2009). For this reason, 




Hypothesis 2: GDS-15 scores will be a significant predictor of AAQ Psychosocial 
Loss scores.  
 
 A multiple regression model was used to examine how well depression, quality of 
life and satisfaction with health predict attitudes to ageing. All participants were 
therefore included in this analysis, including the clinically depressed group (n = 28), 
the depressed controls (n = 15) and the non depressed controls (n = 42). It is 
recommended that sample sizes for multiple regression are calculated using the 
formula: n = 50 + 8k, where k is the number of variables entered (Green, 1991). A 
multiple regression was conducted using three independent variables, therefore using 
this formula, a sample size of 74 participants was required to obtain power for this 
analysis. A total of 85 participants were included in the final analysis.  
 
Hypothesis 3: Negative attitudes to ageing will be correlated with poorer quality of 
life. 
Hypothesis 4: Negative attitudes to ageing will be correlated with increased 
hopelessness. 
Hypothesis 5: Negative attitudes to ageing will be correlated with higher 
endorsement of the understandability phenomenon. 
Hypothesis 6: Negative attitudes to ageing will be correlated with increased 
subjective memory complaints. 
Hypothesis 7: Negative attitudes to ageing will be correlated with increased anxiety. 
 
Hypotheses three to seven examined correlations between AAQ and other variables 
within only the clinically depressed group. Correlational analyses were conducted for 
68 
 
the remaining hypotheses. Cohen’s tables (1992) were consulted for obtaining a 
sample size for this analysis. Assuming a large effect size at power 0.8 and alpha 
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Background: Negative ageing stereotypes are prevalent in society and can have 
significant effects on older people’s attitudes towards their own ageing. Late life 
depression has been shown to be associated with negative attitudes to ageing and 
poorer quality of life. However, attitudes to ageing have not yet been explored within 
a clinical population. The aim of this study was to explore attitudes to ageing within 
a clinically depressed sample of older adults. Method: Twenty eight clinically 
depressed adults over the age of 65 participated in this study. They were compared 
with a control sample of non depressed older adults (n = 42). All participants 
completed self report questionnaires including: Attitudes to Ageing Questionnaire, 
Geriatric Depression Scale and the WHO Quality of Life assessment – Brief version. 
The clinically depressed participants completed additional measures, including: 
Geriatric Anxiety Scale, Beck Hopelessness Scale, Prospective and Retrospective 
Memory Questionnaire, and the ‘Understandability’ Questionnaire. Results: 
Attitudes to ageing were found to be significantly more negative in the clinically 
depressed sample compared with non depressed controls. Increased depressive 
symptoms are associated with negative attitudes to ageing and depression was found 
to be a significant predictor of negative attitudes relating to psychosocial loss. 
Negative attitudes to ageing were also correlated with hopelessness, reduced quality 
of life and lower satisfaction with health. Conclusion: These findings are of clinical 
relevance as attitudes to ageing appear to be mood-state dependent. Therefore, they 
may be amenable to change through psychological therapies which aim to challenge 
dysfunctional beliefs. Keywords: attitudes, ageing, depression, older people. 





Demographic changes indicate that life expectancy is rising and birth rates are 
falling, which is resulting in an ageing population. This unprecedented worldwide 
demographic change is profound and irreversible (UNFPA, 2012). Currently 1 in 6 
of the UK’s population are over the age of 65, however, this is set to rise to 1 in 4 by 
2035 (Office for National Statistics, 2012). The population of the ‘oldest old’ (those 
aged over 85) is projected to rise most quickly, with numbers doubling by 2030 
(Laidlaw & Pachana, 2009). There are important implications for this demographic 
change and this has been reflected in government policies, with recent emphasis on 
issues regarding the health and well being of older people (Scottish Executive, 2007). 
This ageing population will present challenges for health care provision (UN, 2009) 
and it is likely that there will be an increased demand for mental health services for 
older people. A recent report from the House of Lords stated that the UK is currently 
underprepared for the ageing population and that changes to societal attitudes 
regarding ageing are required (HL Paper 140, UK 2013).  
 
Depression in older people 
 
Depression is one of the most common mental health problems in later life (Luppa et 
al., 2012) and it can have a detrimental impact on an individual’s morbidity and 
mortality (Covinsky et al., 1999). However, depression is often undiagnosed in older 
people (Alexopoulos, 2005) and they are less likely to receive psychological support 
than their younger counterparts (Unutzer et al., 2003). One reason for this may be 
due to negative ageing stereotypes (Linden & Kurtz, 2009). Given the challenges of 
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old age, such as poorer physical health and losses, depressive symptoms in late life 
may be interpreted as understandable and an inevitable consequence of ageing (Law 
et al., 2010). This has been termed the ‘understandability’ phenomenon (Blanchard, 
1992). Such beliefs may result in older people being less likely to seek help for their 
depression (Sarkisian et al., 2003). Another aspect of this phenomenon is that health 
professionals may hold these beliefs (consciously or subconsciously). Attributing 
psychological problems to ageing rather than depression can have a significant 
impact on the efficacy of psychological treatments. For example, if therapists accept 
older adults’ erroneous beliefs about ageing such as ‘I’m depressed but what should I 
expect at my age’, this may increase the therapist’s hopelessness since age is 
unchangeable, and may result in therapy becoming unfocussed and unhelpful 




Despite an increase in risk factors for depression as people get older, evidence 
suggests there is a lower frequency of depression in late life than in younger 
adulthood or middle age (Sadavoy, 2009). Blazer (2010) suggests three protective 
factors associated with ageing that may explain this apparently paradoxical finding: 
better emotional regulation skills; increased wisdom; and resilience as older people 
cope better with stressful life events. Socio-emotional selectivity theory (Carstensen 
et al., 1999) suggests that as people age, priorities and motivations change with older 
people placing greater emphasis on goals relating to ensuring current emotional 
stability such as investing in existing social relationships, rather than on goals 
relating to the future, such as acquiring knowledge or building new social networks. 
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As a result, emotional wellbeing and emotional stability improve with age 
(Carstensen et al., 2011). This is in contrast to previously commonly held beliefs 
about older people being less likely to benefit from psychotherapy due to being more 
rigid and ‘set in their ways’. Conversely, it seems that older people are more adept at 
emotion regulation therefore they may be more or as psychologically minded as 
younger people and thus, equally able to benefit from psychotherapy.  
 
Another factor that may help explain the ageing paradox is that older adults are 
thought to have increased wisdom (Laidlaw, 2010; 2013), which may be protective 
against depression. Using their wisdom and life experience may allow older people 
to better manage stressful life events. In particular, older people are more adept at 
anticipating potentially stressful life events and therefore minimising negative 
emotions associated with them (Scheibe & Carstensen, 2010). 
 
Attitudes to ageing 
 
Research has shown that ageing is often viewed in a negative light, being thought of 
as a time of deterioration, for example, reduced physical and cognitive functioning 
(Sarkisian et al., 2005). Despite the stereotypes, there is increasing interest in older 
people’s actual experiences of ageing. Diehl and Werner-Wahl (2010) suggest that 
ageing experiences can be understood by individuals’ awareness of age related 
changes (AARC; Diehl & Werner-Wahl, 2010). They propose that the experience of 
ageing has less to do with chronological age and more to do with subjective 
attributions of changes that signify old age. For example, a sense of ageing may 
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come from the meaning one attributes to noticing a slower processing speed, rather 
than simply becoming slower.  
 
Levy (2009) suggests that awareness of age related changes may be biased towards 
the negative aspects of ageing. She proposed that ageing stereotypes are internalised 
early in childhood due to repeated exposure and societal reinforcement. However, it 
is only when children become part of the stereotyped group (older adults) that these 
stereotypes become ‘self stereotypes’. Levy (2003) proposes that negative self 
stereotypes can have a detrimental impact on older adults cognitive and physical 
functioning. A series of laboratory experiments were conducted involving subliminal 
priming of age stereotypes in older adults. Positive or negative age stereotype words 
were flashed on a computer screen, too quickly to allow conscious awareness but 
slow enough to be perceived. It was found that older adults who were primed with 
the negative stereotypes subsequently performed worse on cognitive tasks (Levy, 
1996; Hess et al., 2002). It was also found that being primed with negative 
stereotypes affected subjects’ gait (Hansdorff et al., 1999); their handwriting (Levy, 
2000); their will to live (Levy et al., 2002); and their cardiovascular functioning 
(Levy et al., 2000). Levy et al. (2002) carried out longitudinal studies and discovered 
that people with more positive self perceptions of ageing lived on average 7.5 years 
longer that those who had negative self perceptions of ageing. This was after 
controlling for a range of factors including physical health. Moser et al. (2011) 
studied the effects of negative self perceptions of ageing on the risk of adverse 
outcomes and adaptive living skills. They found a strong association between 
negative perceptions of ageing and future vulnerability to difficulties with adaptive 
living skills. Negative self perceptions of ageing have also been found to affect the 
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likelihood of a person engaging in positive health behaviours (Levy & Myers, 2004; 
Quinn et al., 2009). 
 
Ageing stereotypes operate both implicitly and explicitly but have been shown to be 
more negative when operating outwith awareness. Levy (2009) stated that people 
tend to be unaware and unprepared for negative self stereotypes and therefore do not 
tend to challenge them when they reach old age. Larzelere et al. (2011) reported that 
when implicit stereotypes are made explicit (when people become aware that 
negative self stereotypes have been activated), the effects that Levy and colleagues 
have shown are not apparent. This is an important finding suggesting that ageism and 
its effects are preventable and changeable. 
 
Measuring attitudes to ageing 
 
Ageing processes are therefore complex and it is important that there are suitable 
tools for examining attitudes to ageing since attitudes are known to affect a range of 
health outcomes (Bryant et al., 2012), including changes in mood, behaviour and 
physical health problems. A range of questionnaires have been developed to assess 
attitudes to ageing. Some explore attitudes at a societal level, for example, the Facts 
on Ageing Quiz (Palmore, 1977) and the Ageing Semantic Differential (Rosencranz 
& McNevin, 1969) which both tap into stereotypes about older people. Others 
measure attitudes at a personal level. For example, the Reactions to Ageing 
Questionnaire (Gething, 1994) which is used to assess reactions that individuals have 
in anticipation of their own ageing. A measure commonly used for exploring 
attitudes to their own ageing is a five item subscale of the Philadelphia Geriatric 
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Morale Scale (Lawton, 1975). However, Laidlaw et al.’s (2007) study recently 
developed the Attitudes to Ageing Questionnaire (AAQ) in order to measure older 
people’s attitudes to their own ageing. This comprehensive questionnaire comprises 
three subscales which recognise both positive and negative aspects of ageing and it 
has demonstrated good psychometrics and cross cultural reliability. 
 
Previous research using AAQ 
 
There has been limited research to date using the AAQ. Those studies that have used 
this measure have shown that negative attitudes to depression are linked to negative 
attitudes to ageing (Quinn et al., 2009). It has also been shown that having depression 
(regardless of attitude to depression) has been linked to negative attitudes to ageing 
(Chachamovich et al., 2008). This effect was still found in people with sub-
syndromal depression. In particular, they found that depression was a significant 
predictor of scores on the Psychosocial Loss subscale of the AAQ. The AAQ has 
also recently been used in a sample of people with dementia (Trigg et al., 2012) and 
it was concluded that people with dementia showed more negative attitudes to 
ageing. Additionally, these negative attitudes had an impact on the quality of life 
experienced by people with dementia. Bryant et al.’s (2012) study explored attitudes 
to ageing using the AAQ and its relationship to self reported physical and mental 
health, and satisfaction with life in a community dwelling sample of 421 people over 
the age of 60. They found that positive attitudes were linked with increased 
satisfaction with life and better self reported physical and mental health. They also 




Rationale for current study  
Attitudes to ageing have been explored in community dwelling older adults, and 
links have been found between depressive symptoms and negative attitudes. Other 
factors have also been shown to correlate with negative attitudes to ageing, including 
poorer quality of life and poorer subjective physical health (Ron, 2007). It has 
previously been suggested that feeling older is associated with negative views about 
cognitive functioning (Schafer & Shippee, 2010). Exploring attitudes to ageing in 
relation to other factors within a clinical sample will contribute to an increased 
understanding older people’s views of their own ageing and how this may relate to 
their wellbeing.  
 
Exploring the attitudes of clinically depressed older people will have implications for 
the treatment of late life depression. Cognitive theory suggests that dysfunctional 
attitudes are mood state dependent (Laidlaw, 2010) and therefore amenable to 
change. It has been suggested that challenging attitudes and beliefs about ageing, for 
example, using standard CBT techniques, may be an effective component for treating 
depression (Laidlaw, 2010).  
 
Aims 
This study aims to compare attitudes to ageing in a clinically depressed sample of 
older adults and non depressed older adults. It is hypothesised that the clinically 
depressed sample will show more negative attitudes to ageing than the non depressed 
control sample. Additionally, this study aims to correlate attitudes to ageing with 
other factors including anxiety, subjective memory, hopelessness, quality of life, and 






Participants in this study included 28 people (15 male: 13 female) over the age of 60 
with depression who were receiving input from community mental health teams 
(CMHTs). Participants were recruited through CMHT clinicians already involved in 
their care. Inclusion criteria were: a diagnosis of depression, a score of five or above 
on the GDS-15, and aged over 60 years. Exclusion criteria were: cognitive 
impairment, substance misuse or psychosis. Clinicians were asked to identify 
patients on their caseloads who met these criteria. Clinicians then offered potential 
participants a questionnaire pack, which contained an information sheet, seven self 
report questionnaires and a stamped addressed envelope. Potential participants could 
then decide whether or not they would like to complete the questionnaires and return 
to the researcher anonymously. In total, 370 questionnaire packs were distributed to 
clinicians (220 in NHS Highland and 150 in NHS Grampian). In total, 28 
questionnaire packs were returned (20 from NHS Highland and 8 from NHS 
Grampian). Of the packs distributed within the health boards, it was not possible to 
determine how many packs were distributed to potential participants, thus an 
accurate response rate was not calculated.  
 
Control group data was accessed through existing data held form a sample of healthy 
older adults who were recruited in the Lothian and Fife areas as part of the AAQ 
field trial (Laidlaw et al., 2007). Control participants were healthy adults over the age 





For the depressed participants, demographic information was collected by means of a 
questionnaire which included information on: age, gender, living arrangements, 
employment status, education level, relationship status and subjective health status 
(healthy or unhealthy). Participants also completed seven self report measures, each 
of which is briefly outlined below. 
 
Attitudes to Ageing Questionnaire (AAQ; Laidlaw et al., 2007) 
The AAQ is a 24-item self report measure that was developed to assess older 
people’s attitudes towards their own ageing, both positive and negative. The items 
are divided among three domains. Firstly, psychosocial loss, which focuses on the 
psychological losses associated with old age, for example, ‘old age is a time of 
loneliness’. Secondly, physical change, which relates to the changes in physical 
functioning and attitude to health and exercise, for example, ‘I keep as fit and active 
as possible by exercising’. The third subscale is psychological growth, which focuses 
on the positive aspects of ageing, for example, ‘wisdom comes with age’. Each item 
is rated on a 5-point Likert scale and the scores are totalled for each subscale, 
resulting in a minimum score of eight and a maximum score of 40. 
 
Geriatric Depression Scale – short form (GDS-15; Sheikh & Yesavage, 1986) 
The GDS-15 is a widely used standardised measure for assessing depression in older 
adults. Responses are entered as ‘yes’ or ‘no’ and a score of five or above is used as a 





Geriatric Anxiety Inventory – short form (GAI-SF; Byrne & Pachana, 2011) 
Anxiety is often co-morbid with late life depression. The GAI-SF is a 5-item self 
report measure of anxiety. It has demonstrated validity and is recommended for use 
in research.  
 
World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF; WHO, 
1996)   
The WHOQOL–BREF is a 26-item measure that assesses quality of life in four 
domains: physical, psychological, social and environmental. It was developed from 
the WHOQOL-100 and has shown good internal consistency. Scores on the 
WHOQOL-BREF are transformed to scores between 0-100 in order to correspond 
with the WHOQOL-100. 
 
Prospective and Retrospective Memory Questionnaire (PRMQ; Smith et al., 2000) 
The PRMQ is a 16-item self report measure that assesses an individual’s subjective 
memory (both prospective and retrospective memory). Crawford et al. (2003) 
demonstrated that the PRMQ has good reliability and scores are not influenced by 
age.  
 
Understandability Questionnaire (Law et al., 2010) 
The understandability questionnaire was developed to measure the belief that 
depression is a normal consequence of old age. It comprises three attitudinal 





Beck Hopelessness Scale (BHS; Beck & Steer, 1988) 
The BHS measures three aspects of hopelessness: feelings about the future, loss of 
motivation and expectations. It comprises 20 items which are rated true or false. 
 
The control participants had previously completed the AAQ, GDS-30 and a 
demographics questionnaire as part of the earlier study (Laidlaw et al., 2007). The 
demographic questionnaire included information on: age, gender, marital status, 
living arrangements, education level and subjective health status (healthy or 
unhealthy). The GDS-30 results were pro-rated so that the scores were equivalent to 
the GDS-15. The GDS-30 contains all 15 questions in the GDS-15, therefore the 
results for the GDS-30 were examined and the questions that were surplus to the 
GDS-15 questions were removed. 
 
Both the control group and the clinically depressed group also completed two single 
item questions that were measured on a five point Likert scale. Participants were 














There were 31 questionnaire packs returned during the recruitment period. Three of 
these scored below five on the GDS-15, indicated no presence of low mood. 
Therefore, there were 28 clinically depressed participants included in this study. An 
existing dataset was used to collect control participants’ data (n = 116). Within this 
control sample, participants with missing data were removed. Additionally, 
participants over the age of 90 and under the age of 65 were removed from the 
control group in order to ensure groups were more evenly matched on age. This 
resulted in a sample size of 57 in the control group. Of these control participants, 15 
scored five or above on the GDS-15, which indicates depression. Therefore, this 
resulted in three sets of data that were used in the analyses:  
 
 Dataset 1: Clinically depressed group (n = 28)  
 
 Dataset 2: Non-depressed controls (n = 42) 
 
 Dataset 3: All depressed participants (n = 43; comprising 28 clinically 
depressed and 15 symptomatically depressed participants from the AAQ field 









Seven individual hypotheses were tested: 
 
A. Comparing clinically depressed sample (n = 28) and non depressed control 
sample (n = 42) 
- Hypothesis 1: The clinically depressed sample will have significantly more 
negative attitudes to ageing on the Psychosocial Loss subscale compared to 
the non depressed control sample. 
  
B. Comprising all participants scoring >5 on GDS-15 with non depressed 
controls (n = 85) 
- Hypothesis 2: GDS-15 scores will be a significant predictor of AAQ 
Psychosocial Loss scores.  
 
C. Comprising only the clinically depressed sample (n = 28) 
- Hypothesis 3: Negative attitudes to ageing will be correlated with poorer 
quality of life 
- Hypothesis 4: Negative attitudes to ageing will be correlated with increased 
hopelessness 
- Hypothesis 5: Negative attitudes to ageing will be correlated with higher 
endorsement of the understandability phenomenon 
- Hypothesis 6: Negative attitudes to ageing will be correlated with increased 
subjective memory complaints 






Exploratory data analysis  
 
Preliminary analyses were carried out to assess the normality of the distribution of 
data. Visual inspection of histograms and QQ plots were used to assess for skew, 
kurtosis and outliers. Kolmogorov-Smirnov tests were conducted to assess for 
normality and Levene’s test was used to assess for homogeneity of variance. 
Variables that violated these assumptions of normality included: ‘Quality of Life’ 
(rated 1-5) and ‘Satisfaction with Health’ (rated 1-5). These variables were analysed 
using non-parametric tests rather than transforming the data.  In preparation for the 
correlational analyses, scatterplots were also examined. For variables that were 
normally distributed, Pearson correlations were conducted and for variables that were 
not normally distributed, the non parametric equivalent was used (i.e. Spearman rank 
order coefficient). Due to the multiple correlations being made, a more stringent 
alpha level of 0.01 was used to assess for significance. In relation to multiple 
regression, assumptions were checked, including multicollinearity, normality, 
outliers and homoscedacity, none of which were violated. 
 
Sample characteristics  
 
Independent sample t-tests or non-parametric equivalent (i.e. Mann Whitney U test) 
and chi squared tests were used to compare groups on demographic variables. The 
depressed group (n = 28) was compared with the non-depressed control group (n = 
42). The characteristics are detailed in Table 1.1. 
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Mean (SD) Or 
N (%) 
Non-depressed 
Mean (SD) or 
N (%) 






GDS-15 Score  10.0 (2.8) 2.0 (1.5) 2.2 <.001 
Self rated quality of 
life 
2.7 (1.1) 4.1 (0.7) 5.1 <.001 
Self rated satisfaction 
with health 
2.8 (1.2) 3.7 (0.9) 2.9 .003 
Age 75 (6.6) 79 (7.1) 2.2 .031 
Gender 
     Male 









    Married 
    Separated/Single  











    Living with family 
    Living alone  
    Residential or   











    Healthy 









    Secondary School 
    Trade Certificate 
    College diploma or  













As indicated in Table 1.1, there were no significant differences between the clinically 
depressed group and the non depressed group in relation to marital status (χ
2
 = 3.2, p 
= .202) or education level (χ
2
 = 1.2, p = .541). As expected, the clinically depressed 
group had significantly higher GDS-15 scores than the control group (t(69) = 2.2, p < 
.001, two-tailed). The depressed group rated their quality of life lower than the 
control group and they were less satisfied with their health. The mean age of the 
depressed group was 75 and of the control group was 79, and this difference was 
statically significant (t(69) = 2.2, p = .03, two-tailed). There were significant group 
differences on other demographic variables, including living arrangements (χ
2
 = 19.8, 
p < .001); gender (χ
2
 = 4.3, p = .04) and subjective health status (χ
2
 = 9.4, p = .002). 
 
Hypothesis driven results 
 
Hypothesis 1: The clinically depressed sample will have significantly more 
negative attitudes to ageing on the Psychosocial Loss subscale compared to 
the non depressed control sample.  
 
A one way ANOVA was conducted to compare groups on the AAQ subscales. The 
means and standard deviations are shown in Table 1.2. Higher AAQ scores indicate 
















(n = 42) 
Mean (SD) 
F Value Significance 
AAQ Total 73.6 (10.5) 82.5 (9.4) 13.8 p < .001 
Psychosocial 
Loss 
22.4 (4.9) 30.9 (3.7) 67.5 p < .001 
Physical Change 24.3 (5.5) 25.0 (4.0) .4 p = .546 
Psychological 
Growth 
26.9 (5.7) 26.6 (4.2) .1 p = .811 
 
As shown in Table 1.2, there was a statistically significant difference between groups 
on the AAQ Total (F(1, 68) = 13.8, p < .001) and on the Psychosocial Loss subscale 
(F(1, 68) = 67.5, p < .001). No significant differences were found between groups on 
the Physical Change subscale (F(1, 68) = 0.4, p = .546) nor the Psychological Growth 
subscale (F(1, 68) = 0.1, p = .811).  
 
Hypothesis 2: GDS-15 scores will be a significant predictor of AAQ 
Psychosocial Loss scores.  
 
Prior to including all participants in this analysis, independent samples t-tests or chi 
squared analyses were conducted in order to compare the clinically depressed sample 
and the depressed controls on demographic variables. There were no significant 
differences in age, gender, marital status or education level. There was a significant 
difference in living arrangements (χ
2
 = 14.6, p = .001) with more of the clinically 
depressed group living alone. There was also a significant difference in severity of 
depression with the clinically depressed group reporting higher GDS-15 scores (M = 
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10.0, SD = 2.8) compared with the depressed controls (M = 7.9, SD = 6.9; t(41) = 
2.6, p = .014).  
 
Prior to conducting a multiple regression, Pearson correlations were conducted to 
explore the associations between attitudes to ageing and depression level within the 
whole sample (n = 85: 28 clinically depressed, 15 depressed controls and 42 non 
depressed controls). All variables, including demographic variables, were entered 
into the correlation matrix and three variables were found to significantly correlate 
with the AAQ, as shown in Table 1.3.  
 












GDS-15 Score -.577** -.720** -.317** -.213* 
Quality of Life .497** .485** .398** .174 
Satisfaction with 
Health 
.512** .377** .441** .285** 
** significant at p<0.01 * significant at p<0.05 
 
Strong correlations were found between GDS-15 scores and AAQ total (r = -.577, p 
< .001), and between GDS-15 scores and Psychosocial Loss (r = -.720, p < .001). A 
medium correlation was found between depression and attitudes on the Physical 
Change subscale (r = -.317, p = .003). The direction of the associations suggests that 
as depressive symptoms increase, overall attitudes to ageing and attitudes in relation 
to Psychosocial Loss and Physical Change become more negative. This analysis also 
demonstrated that GDS-15 scores were negatively correlated with Quality of Life (r 
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= -.699, p < .001) and negatively correlated with Satisfaction with Health (r = -.487, 
p < .001). 
 
Multiple Regression  
Previous studies have examined the impact that depression has on older people’s 
attitudes to ageing. Chachamovich et al. (2008) included depression as a predictor 
variable in their multiple regression model and found that it accounted for the 
majority of the variance in attitudes to ageing. The current study included 
participants with clinical depression and aimed to predict attitudes to ageing based on 
depression level. If clinical depression has an effect on attitudes to ageing then it can 
be suggested that such attitudes are mood-state dependent. A multiple regression was 
therefore conducted using depression (GDS-15 scores) as a predictor variable. 
Quality of life and Satisfaction with Health were also entered into the model as 
predictor variables as prior Pearson correlations showed significant associations 
between these variables and the AAQ subscales. The remaining variables were not 
entered as they showed no significant correlations with the AAQ. The results of the 
multiple regression are shown in Table 1.4. 
 
Table 1.4 Multiple Regression model 
Predictor 
Psychosocial Loss Physical Change 
B (SE) Beta P value B (SE) Beta P value 
GDS-15 Scores 33.0 (.15) -.725 < .001 .064 (.12) .054 .699 
Quality of Life -.248 (.61) -.046 .685 1.30 (.68) .269 .059 




The AAQ was developed to report profile scores (Laidlaw et al., 2007) and the AAQ 
Total scale is a composite score. For this reason it was not included in the multiple 
regression. With regard to the Psychosocial Loss subscale, the regression model 
explained 51.5 per cent of the variance (F(3,81) = 28.7, p < .001). Depression made the 
largest unique contribution (Beta = -.725). With regard to the Physical Change 
subscale, the model explained 23.8 per cent of the variance in attitudes (F(3,81) = 8.4, 
p < .001). Of the variables, Satisfaction with Health made a significant contribution 
(Beta = .333). With regard to the Psychological Growth subscale, the regression 
model did not reach significance (R
2
 = .085, p = .06). 
 
Hypotheses 3 – 7 (Correlational Analyses) 
 
The clinically depressed group completed additional questionnaires to the control 
group. Hypotheses three to seven therefore relate to correlations carried out within 
the clinically depressed group (n=28), to assess associations between AAQ subscales 
and each of the additional measures. Pearson correlations were conducted for data 
that met the assumptions for parametric tests and Spearman rank order coefficients 
are reported for data that did not meet assumptions of normality.  
 
Hypothesis 3: WHOQOL-BREF: Negative attitudes to ageing will be 
correlated with poorer quality of life.  
 
As illustrated in Table 1.5, attitudes to ageing were significantly positively correlated 
with psychological and environmental quality of life, though correlations with 
physical quality of life were nonsignificant and there was no association between 
91 
 
attitudes to ageing and social quality of life. This indicates that higher environmental 
or psychological quality of life was significantly associated with more positive 
attitudes to ageing.  
 









WHOQOL Physical # .312 .379 .229 
WHOQOL 
Psychological # 
.267 .707** .528** 
WHOQOL Social .212 .001 -.086 
WHOQOL 
Environmental # 
.461* .371 .394* 
BHS -.416* -.374 -.558** 
Understandability .221 .377 .280 
GAI # -.275 -.256 -.039 
PRMQ .107 -.340 -.460* 
** significant at p<0.01 * significant at p<0.05 # Spearman’s rho 
 
Hypothesis 4: Beck Hopelessness Scale: Negative attitudes to ageing on the 
Psychosocial Loss subscale will be correlated with increased hopelessness.  
 
As hypothesised, a significant and negative correlation was found between 
Psychosocial Loss and hopelessness (r = -.416, p = .043) which indicates that 
increased levels of hopelessness are associated with more negative attitudes to 
ageing. This effect, however, was not significant at the level of p < 0.01. It was also 
found that increased hopelessness was associated with negative attitudes to ageing on 
the Psychological Growth subscale (r = -.558, p = .006). 
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Hypothesis 5: Understandability Questionnaire: Negative attitudes to ageing 
will be correlated with higher endorsement of the understandability 
phenomenon.  
 
No significant correlations were found between negative attitudes to ageing and the 
understandability phenomenon. However, positive correlations were found between 
the total AAQ scores and endorsement of the understandability phenomenon (r = 
.481, p = .011). This indicates an association between negative attitudes to ageing 
and increased belief that late life depression is understandable, though this 
correlation was not significant after adjusting the alpha level for multiple 
correlations. 
 
Hypothesis 6: Geriatric Anxiety Inventory: Negative attitudes to ageing will 
be correlated with increased anxiety. 
 
It was found that as self reported anxiety increases, attitudes to ageing become more 
negative, however, these correlations were not statistically significant.   
 
Hypothesis 7: PRMQ: Negative attitudes to ageing will be correlated with 
increased subjective memory complaints. 
 
Negative attitudes to ageing on the Psychological Growth subscale were significantly 
correlated with increased subjective memory problems (r = -.460, p = .016). There 







The aim of the current study was to examine attitudes to ageing in a clinical sample 
of depressed older adults. As hypothesised, participants in the clinically depressed 
sample reported significantly more negative attitudes to ageing in relation to 
Psychosocial Loss than the non depressed control group. There were no differences 
between groups with regard to the other subscales, Psychological Growth and 
Physical Change, which are positively framed. This is consistent with the ageing 
paradox; despite challenges associated with ageing, older people tend to report high 
subjective wellbeing. Kunzmann et al. (2000) reported that the concept of subjective 
well being was relatively stable in older people, whereas negative attitudes have been 
shown to be mood-state dependent (Miranda & Persons, 1988). Within the whole 
sample, significant negative correlations were found between attitudes to ageing (on 
all three subscales of the AAQ) and level of depression. In particular, depression was 
found to be a significant predictor of scores on the Psychosocial Loss subscale. The 
effect was large, with the regression model accounting for 51.5 per cent of the 
variance in Psychosocial Loss. This finding is consistent with the results of 
Chachamovich et al.’s (2008) study which showed that both depression and quality 
of life were significant predictors of attitudes to ageing. The results also confirm 
other research findings correlating depression and negative attitudes in relation to 
Psychosocial Loss (Bryant et al., 2012; Quinn et al., 2009). 
 
Negative attitudes to ageing on the Psychosocial Loss subscale are therefore likely to 
be reflective of depressive attributions about ageing and this is not surprising given 
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that loss is a key cognitive theme in depression. Beck et al.’s (1979) cognitive theory 
states that individuals with depression have dysfunctional beliefs about themselves, 
the world and the future. In a stress-diathesis model, pre-existing vulnerabilities to 
depression and negative beliefs can be triggered by stressful life events, resulting in 
depression. The finding that depressed older adults reported more negative attitudes 
to ageing than non depressed older adults supports the theory that dysfunctional 
attitudes are mood-state dependent. In late life depression, it may be that stressful life 
events associated with ageing (such as losses) trigger latent negative ageing 
stereotypes to become salient, resulting in depressed mood. Ageism, both implicit 
and explicit, is prevalent in society, and the internalisation of negative ageing 
stereotypes can have a range of adverse effects on people when they become older 
(Levy, 2009). It has been shown that older people are generally positive about 
ageing, therefore society must re-evaluate its erroneous perceptions of ageing in 
order to promote positive attitudes to ageing.  
 
With regard to the other hypotheses, increased hopelessness was correlated with 
negative attitudes to ageing in relation to Psychosocial Loss, as expected. 
Hopelessness was also correlated with the understandability phenomenon, suggesting 
that beliefs about late life depression being normal are associated with feelings of 
hopelessness. This may have significant implications for psychological therapies as 
challenging negative and erroneous attitudes about ageing and depression may 
increase hope and treatment efficacy.   
 
There were no significant associations between attitudes to ageing and anxiety. This 
is in contrast to previous research findings indicating that positive attitudes on the 
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Psychosocial Loss subscale were linked with reduced anxiety (Bryant et al., 2012). 
The non significant finding in the current study may be due to the fact that the 
shorter five item GAI was used, while Bryant et al. (2012) used the full 20-item GAI. 
Anxiety is often co-morbid with depression in older people and it may be more 
prevalent than depression (Laidlaw, 2013). The link between anxiety and attitudes to 
ageing should be explored further.  
 
Ageing is often stereotypically thought of as a time of reduced physical and cognitive 
functioning (Mulley, 2007). Feeling older has been associated with poorer subjective 
cognitive functioning (Shafer & Shippee, 2010), however, the link between attitudes 
to ageing and subjective memory functioning has not been fully explored. The 
current study found no correlation between the AAQ and subjective memory. It may 
be that older people experiencing subjective memory complaints have more negative 
ageing beliefs, however, the current sample could have been too small to detect any 
correlation. Trigg et al.’s (2012) study found that people with dementia reported 
more negative Psychosocial Loss scores. Interestingly they reported that awareness 
of memory deficits significantly predicted AAQ scores, whereas actual memory 
functioning did not.   
 
Strengths and limitations of study 
A strength of this study is that it corroborates previous research using the AAQ and 
provides strong evidence for the role of attitudes to ageing in late life depression. The 
majority of measures used in this study were designed for older people and 
demonstrate good psychometric properties. This study is the first to use the AAQ in a 
clinical sample of depressed people. Given that this is the population that clinicians 
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within CMHTs will be in contact with, the results provide valuable insight into older 
people’s own experiences of ageing.  
 
The results of the study must be considered in the context of several limitations. The 
small sample size of clinically depressed participants limits the generalisability of the 
results. Despite over 350 questionnaire packs being distributed to CMHTs, only 31 
were returned to the researcher (28 of which were suitable for inclusion in the 
depressed sample). This low response rate is likely to have been affected by the 
recruitment strategy. The recruitment method was designed to maximise informed 
consent and minimise the possibly of patients feeling obligated to participate. 
However, this required a degree of effort and concentration on the part of the patient 
in order to read the information and complete the large number of questionnaires, 
which may have affected the accuracy of responses as well as the response rate. The 
complexity of the target population and the effect that this may have on participants’ 
ability and willingness to complete the questionnaires accurately may also have 
contributed to the difficulty recruiting a larger sample size.  Additionally, it is likely 
that clinicians did not hand out the packs to all suitable participants, indicating a 
possible selection bias. Therefore, this sample may not be an accurate representation 
of the clinical population of depressed older adults. 
 
The small sample size also affected the choice of statistical analysis that could be 
used. Multiple regression models would have been more informative in determining 
what factors are influencing attitudes to ageing. However, correlational analyses 
have provided an exploration of the data within this population. The cross sectional 




The results of this study highlight the importance of the effect that negative attitudes 
to ageing can have on a range of physical and mental health outcomes. This study 
confirmed previous research findings which have indicated that that negative 
attitudes to ageing have a detrimental effect on self reported quality of life 
(Chachamovich et al., 2008). Psychological therapies such as CBT, which aim to 
challenge dysfunctional thoughts and beliefs, have been shown to be effective for 
late life depression therefore improving attitudes may in turn improve quality of life.  
This has implications for the treatment of late life depression. In an older person with 
depression, attributing mood to ageing may exacerbate feelings of hopelessness as 
age is unchangeable. Furthermore, underlying beliefs that little can be done about 
late life depression may reduce likelihood of individuals seeking help and if they do, 
it may also significantly reduce expectations for treatment success. Therapists must 
therefore assess attitudes to ageing in depressed older adults as dysfunctional 
attitudes may be become obstacles during therapy if left unchallenged. Additionally, 
clinicians must be aware of their own attitudes about ageing as this too may affect 
treatment expectations. Charlesworth and Greenfield (2004) stated that therapists’ 
ageist beliefs can lead to therapeutic nihilism if not addressed. This highlights the 
necessity of clinical supervision to facilitate therapists’ self reflection.  
 
With the demographic changes indicating a growing older adult population, there 
will be an increasing demand for psychotherapy for older people. Therapists must be 
knowledgeable regarding gerontological theories when working with older people in 
order for therapy to remain effective. Increasing access to psychological therapies for 
older people has recently become a national priority.  The need for specialist services 
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for older people has been highlighted (NES, 2011) and this is evidenced by 
increasing training for psychological therapies with older people. Therapy can be 
augmented using theories of successful ageing such as selective optimisation with 
compensation (SOC; Baltes, 1997) or by enhancing resilience and wisdom. 
Comprehensive formulations for older people should consider lifespan development 
and include factors such as cohort beliefs, physical changes and role changes 
(Laidlaw et al., 2004). 
 
Further research 
Further research is required to explore other variables in relation to attitudes to 
ageing in order to determine potential mediators. Developing an increased 
understanding of older people’s attitudes towards their own ageing, in relation to 
depression and other mental health problems, could provide information on how 
therapy could be augmented for older people and whether there are attitudes that 
could be targeted.  The AAQ comprises three distinct subscales therefore the AAQ 
may be an optimal tool for researchers to explore ageing attitudes that encompass 
both the positive and the negative aspects of ageing.   
 
Given that the AAQ appears to be a mood-state dependent measure, it may be useful 
to carry out longitudinal research which may provide further information on 
causality. For example, research could examine whether depression is a result of 
negative ageing stereotypes or whether negative attitudes result from depressed 
mood. Research could examine therapies which address attitudes to ageing and 
record measures of attitudes before and after therapy. It would be expected that 
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attitudes to ageing on the psychosocial loss subscale would improve following 




The key findings indicate that older people with depression report significantly more 
negative attitudes to ageing relating to psychosocial loss. Negative attitudes were 
also associated with poorer self reported quality of life, satisfaction with health and 
increased hopelessness. These results highlight the importance of addressing 
attitudes to ageing, both individually and at a societal level. Attitudes are amenable 
to change and challenging dysfunctional attitudes through psychological therapy may 
lead to improvements in mood. Therapists working with older people must be trained 
and knowledgeable in gerontological theories. They must assess for patients’ 
attitudes to ageing and be prepared to challenge their own beliefs about ageing. 
There is a need to change societal attitudes towards older people and ageing in order 
to promote well being in this growing sector of the population, to which we may all 
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Appendix 1: Author Guidelines (Clinical Psychology Review)  
 
Article structure  
Manuscripts should be prepared according to the guidelines set forth in the Publication Manual of the 
American Psychological Association (6th ed., 2009). Of note, section headings should not be 
numbered. 
Manuscripts should ordinarily not exceed 50 pages, including references and tabular material. 
Exceptions may be made with prior approval of the Editor in Chief. Manuscript length can often be 
managed through the judicious use of appendices. In general the References section should be limited 
to citations actually discussed in the text. References to articles solely included in meta-analyses 
should be included in an appendix, which will appear in the on line version of the paper but not in the 
print copy. Similarly, extensive Tables describing study characteristics, containing material published 
elsewhere, or presenting formulas and other technical material should also be included in an appendix. 
Authors can direct readers to the appendices in appropriate places in the text. 
It is authors' responsibility to ensure their reviews are comprehensive and as up to date as possible (at 
least through the prior calendar year) so the data are still current at the time of publication. Authors are 
referred to the PRISMA Guidelines (http://www.prisma-statement.org/statement.htm) for guidance in 
conducting reviews and preparing manuscripts. Adherence to the Guidelines is not required, but is 
recommended to enhance quality of submissions and impact of published papers on the field. 
Appendices  
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in 
appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, 
Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc. 
Abstract  
A concise and factual abstract is required (not exceeding 200 words). This should be typed on a 
separate page following the title page. The abstract should state briefly the purpose of the research, 
the principal results and major conclusions. An abstract is often presented separate from the article, so 
it must be able to stand alone. References should therefore be avoided, but if essential, they must be 
cited in full, without reference to the reference list. 
Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and 
avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with 
abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be 
used for indexing purposes. 
Abbreviations  
Define abbreviations that are not standard in this field in a footnote to be placed on the first page of the 
article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention 
there, as well as in the footnote. Ensure consistency of abbreviations throughout the article. 
Acknowledgements  
Collate acknowledgements in a separate section at the end of the article before the references and do 
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those 
individuals who provided help during the research (e.g., providing language help, writing assistance or 
proof reading the article, etc.). 
Figure captions  
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A 
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep 
text in the illustrations themselves to a minimum but explain all symbols and abbreviations used. 
Tables  
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables 
below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be 
sparing in the use of tables and ensure that the data presented in tables do not duplicate results 




Citations in the text should follow the referencing style used by the American Psychological 
Association. You are referred to the Publication Manual of the American Psychological Association, 
Sixth Edition, ISBN 1-4338-0559-6, copies of which may be ordered from 
http://books.apa.org/books.cfm?id=4200067 or APA Order Dept., P.O.B. 2710, Hyattsville, MD 20784, 
USA or APA, 3 Henrietta Street, London, WC3E 8LU, UK. Details concerning this referencing style can 
also be found at http://humanities.byu.edu/linguistics/Henrichsen/APA/APA01.html 
Citation in text  
Please ensure that every reference cited in the text is also present in the reference list (and vice 
versa). Any references cited in the abstract must be given in full. Unpublished results and personal 
communications are not recommended in the reference list, but may be mentioned in the text. If these 
references are included in the reference list they should follow the standard reference style of the 
journal and should include a substitution of the publication date with either 'Unpublished results' or 
'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted 
for publication. 
Reference style References should be arranged first alphabetically and then further sorted 
chronologically if necessary. More than one reference from the same author(s) in the same year must 
be identified by the letters "a", "b", "c", etc., placed after the year of publication. References should be 
formatted with a hanging indent (i.e., the first line of each reference is flush left while the 



















Appendix 2: Author Guidelines (Psychology and Aging) 
Length 
Manuscripts should not exceed 8,000 words (approximately 27 double-spaced pages in 12-point Times 
New Roman font). Shorter manuscripts are equally welcomed. 
The word count does not include references, tables, and figures. If you feel that you need extra space, 
please contact the editor. For example, you may have a complex methodology or statistical approach 
or a new theoretical framework that requires more text. 
Please include the word count for the main text below the keywords. 
 
Brief Reports 
The Brief Report format is designated for particularly "crisp," theoretically noteworthy contributions that 
meet highest methodological standards. Use 12-point Times New Roman type and 1-inch (2.54-cm) 
margins; include an abstract of 75–100 words; do not exceed 265 lines of text, not including 
references; and typically include no more than two tables or figures. 
 
Manuscript Preparation 
Prepare manuscripts according to the Publication Manual of the American Psychological Association 
(6
th
 edition). Manuscripts may be copyedited for bias-free language (see Chapter 3 of the Publication 
Manual). 
Review APA's Checklist for Manuscript Submission before submitting your article. 
Double-space all copy. Other formatting instructions, as well as instructions on preparing tables, 
figures, references, metrics, and abstracts, appear in the Manual. 
Below are additional instructions regarding the preparation of display equations and tables. 
 
Abstract and Keywords 
All manuscripts must include an abstract containing a maximum of 250 words typed on a separate 





List references in alphabetical order. Each listed reference should be cited in text, and each text 
citation should be listed in the References section. 
Examples of basic reference formats: 
 Journal Article:  
Hughes, G., Desantis, A., & Waszak, F. (2013). Mechanisms of intentional binding and 
sensory attenuation: The role of temporal prediction, temporal control, identity prediction, and 
motor prediction. Psychological Bulletin, 139, 133–151. http://dx.doi.org/10.1037/a0028566 
 Authored Book:  
Rogers, T. T., & McClelland, J. L. (2004). Semantic cognition: A parallel distributed processing 
approach. Cambridge, MA: MIT Press. 
 Chapter in an Edited Book:  
Gill, M. J., & Sypher, B. D. (2009). Workplace incivility and organizational trust. In P. Lutgen-
Sandvik & B. D. Sypher (Eds.), Destructive organizational communication: Processes, 
































































Appendix 6: Participant Information Sheet 
 
Participant Information Sheet – Version 2 
 
 
Study title: Attitudes to ageing and clinical depression in older people. 
 
You are being invited to take part in a research study. Please take time to read this 
information sheet carefully before you decide whether or not you would like to take part.  
 
Thank you for your time. 
 
Why are we doing this research? 
 
The aim of this research project is to explore attitudes to ageing in people who have 
depression. Depression is a common problem for older people, however, it is often 
undiagnosed and older people may not receive the help and treatment that they need. 
Depression can cause a range of symptoms including sleep disturbance, fatigue and sadness. 
When people feel depressed, they also tend to think more negatively. This study aims to 
explore attitudes, particularly relating to ageing. It also aims to explore whether there are 
any links between attitudes and other factors including anxiety and quality of life. Since 
attitudes and beliefs can be changed through psychological therapy, having a greater 
understanding of them may lead to improved interventions for depression in later life.  
 
Why have I been chosen? 
 
We would like to you take part in this study because you are over the age of 60 and have a 
diagnosis of depression.  
 
Do I have to take part? 
 
You do not have to take part in this study. It is up to you to decide whether or not to take 
part. You can withdraw from taking part at anytime during the study, without giving a 
reason, and your current or future treatment will not be affected.  
 
What is involved? 
 
If you would like to take part, you can complete the enclosed questionnaires and return in 
the stamped addressed envelope. If you have any queries about the questionnaires, you can 
phone the researcher for further assistance. All questionnaires will be anonymous. 
 
Will there be any harm in participating in this study? 
 
There will be no harm to you if you participate in this study. If there is anything raised in the 
questionnaires which you find upsetting, the researcher will be available to discuss this with 






Will there be any benefits to taking part in the study? 
 
There will be no direct benefits to you taking part in the study. However, your taking part 
will help us learn more about attitudes to ageing and depression in older people. This may 
then lead to developing more effective psychological treatments for depression in later life.  
 
Will my taking part be kept confidential? 
 
All information collected in this study will be kept strictly confidential. Your name and 
address will not appear on the questionnaires you complete therefore there will be no 
identifiable information on any of the results. You will not be able to be recognised from the 
results of your questionnaires.  
 
What will happen to the results of the study? 
 
This study will be written up as part of the researcher’s Doctorate in Clinical Psychology 
qualification. The results may also be published in a scientific journal. No participant 
identifiable information will be used in any report.  
 
If you would like to receive a summary of the results following completion of the study, you 
can contact the researcher, Alison Raeburn.  
 
Who has organised and reviewed the study? 
 
The study is being funded by the University of Edinburgh. It has been reviewed by 
researchers based in the University and by clinical supervisors in the NHS.  
 
With regard to ensuring participants’ rights, safety and confidentiality, the North of Scotland 
Research Ethics Committee has reviewed the study.  
 
What if there is a problem?  
 
If you have any concerns or if you would like further information, you can speak to the 
researcher, Alison Raeburn, on 01463 253697 and she can answer any questions you have.  
 
If you would like to speak to an independent person about this study, you can speak to Dr 
Brigid Walker, Consultant Clinical Psychologist on 01463 253697. 
 
 
Thank you for considering taking part in this study. 
 
